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1 Introduction
Radiation therapy (RT) is an established method for the treatment of cancer.
The goal of RT is the delivery of a high dose of ionizing radiation to the tumor,
with the purpose of killing the cancer cells, while minimizing dose to the sur-
rounding normal tissue. It is estimated that 50% of the total amount of cancer
patients would benefit from a RT treatment, either as single treatment modality
or in combination with chemotherapy or surgery [1].
The foundation of RT was laid by the discovery of x-rays by Wilhelm Conrad
Röntgen in 1895, and the following discovery of natural radioactivity by Henry
Becquerel in 1896. The potential medical application of these types of ionizing
radiation in terms of diagnosis and therapy was recognized quickly, with first x-
ray treatments starting as soon as 1896 [2]. In 1899, the probably first patient,
a woman with skin cancer, was cured from a malignant tumor with ionizing
radiation [3].
The advantage of fractionated treatment was elaborated by Régaud and
Coutard, beginning in 1919 [4]. They found that if radiation dose was ap-
plied not in a single treatment, but in various fractions, reduced side-effects for
normal tissue could be achieved. This radiobiological concept, which is based
on the reduced DNA repair capability of cancer cells compared to normal cells,
is still exploited today.
In the beginning, external RT was performed with x-ray tubes, similar to those
used in diagnostic radiology. With this technology, tube voltage was limited
to about 250–300 kV. This resulted in a high skin dose with a following steep
decrease in depth dose, as well as a high absorption in bone. Thus, treatment was
limited to superficial tumors. With the emergence of betatrons in the 1940’s,
MeV x-ray energies became available. In the 1950’s, cobalt-60, an emitter of
gamma rays with discrete energies of 1.17 and 1.33 MeV, was introduced as an
alternative radiation source. With higher radiation energies, energy disposition
in deeper body regions became possible. In the 1970’s, linear accelerators (linacs)
were introduced into clinical routine, which are still by far the most common
treatment modality used today. Linacs allow for the application of x-ray energies
of about 4–40MeV [5].
In the phase of early RT, the treatment fields had a very simple, usually rect-
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angular, shape and were planned based on bony landmarks seen on x-ray images,
i.e. two-dimensional projections of the patients anatomy. In the late 1980’s, com-
puted tomography (CT) scanners became increasingly available, allowing for the
acquisition of three-dimensional (3D) representations of the patient. With the
simultaneous development of computerized treatment planning systems (TPS)
3D conformal radiotherapy (3D–CRT) became possible [6]. With this method,
radiation fields are typically applied from different angles around the patient,
and can be adjusted for each angle in geometrical field shape and the contribu-
tion to total dose. Different field shapes are realized either by means of multi leaf
collimators (MLCs) or by specifically shaped blocks. In addition, non-uniform
fields can be achieved by positioning wedges in the radiation field. This allows
for a high conformity of dose to the tumor while sparing nearby organs at risk
(OARs). Organ specific dose constraints exist according to the dose-effect re-
lationship. A prerequisite for 3D-CRT is reproducible patient positioning with
adequate patient fixation systems. For reliable dose delivery, methods for imag-
ing of the patient in the treatment room emerged, including cone-beam CT
scanners attached to the linac.
In the end of the 1990’s, intensity modulated RT (IMRT) has been introduced
in the clinic, adding more flexibility to achievable dose distributions compared
to conventional 3D-CRT [7]. With this technique, not only the fields from dif-
ferent angles are shaped by the MLC, but also the fluence patterns of the fields,
including the possibility to deliver concave fluence cross profiles. This results in
a higher degree of flexibility and complexity compared to conventional 3D-CRT.
In 3D-CRT field shapes and wedges are adjusted by the user until a satisfy-
ing dose distribution is obtained, a process called forward planning. The new
degrees of freedom provided by the concept of IMRT raised the necessity of in-
verse planning algorithms. In this planning concept, the user defines objectives
for the target volume and sets dose constraints for OARs. The treatment plan-
ning algorithm then determines MLC configurations for which the resulting dose
distribution is optimal with respect to these constraints. For dose calculation,
Monte Carlo algorithms [8] emerged, which provide most accurate results, but
typically are only used in the final phase of the planning process due to their
high computational demands.
In addition to photons, also protons and heavier ions, such as carbon ions,
are being evaluated for treatment [9, 10]. Such particle therapy is already ap-
plied clinically, although to a much lesser extent. Proton and ion radiation is
characterized by a clinically favorable depth dose profile, consisting of a slowly
increasing energy disposition up to the very sharp Bragg peak. However, poten-
tial advantages of particle therapy over photon therapy depend on the treatment
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Figure 1.1: (a) Planning CT of a HNC patient with delineation of the gross tumor
volume (GTV) (red) and OARs. OARs visible in this axial representation
consist of left parotid gland (orange), right parotid gland (purple) and
myelon (gold). Patient fixation in treatment position is obtained using
thermoplastic masks. (b) Visualization of the planned total dose distribu-
tion for IMRT treatment of this patient by corresponding dose isocontours.
A total dosis of 70Gy was prescribed to the GTV. The dose sparing of the
OARs can be appreciated.
site and have to be carefully evaluated in clinical studies.
In current clinical practice, standard of care photon treatment is delivered a
fractionated setting with linacs using IMRT. Before the start of RT, a CT is ac-
quired in treatment position, providing the electron density information needed
for dose calculation. On this planning CT, the gross tumor volume (GTV) and
OARs are manually delineated (cf. Figure 1.1 a). With the prescription of a high
homogeneous dose to the target volume consisting of the GTV and additional
safety margins, and specific dose constraints for the OARs, a plan is created
with the TPS (cf. Figure 1.1 b). As an example, a typical RT treatment scheme
for patients with head and neck cancer (HNC) consists of a dose prescription of
70Gy to the tumor, applied in 35 daily fractions of 2Gy each.
Even with the treatment concepts and techniques applied today, there are still
tumor types for which a high fraction of recurrences is observed following RT.
For HNC patients with locally advanced primary tumors, treated with a state
of the art combination of radio- and chemotherapy, up to 50% local recurrences
are observed [11]. Given the high accuracy in dose planning and dose delivery
available today, uncertainties in image-based tumor delineation and the missing
consideration of biological heterogeneity of tumors in current treatment concepts
seem to be major factors limiting the success of RT [12, 13]. In this regard,
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Figure 1.2: Exemplary CT-, MR-, and PET-based imaging data of a HNC patient with
cancer in the hypopharynx, with GTV shown in red. Contrast-enhanced
CT (a), fusion of FDG-PET and CT (b), anatomical MR (T2w STIR) (c),
fusion of FMISO-PET 3h after tracer injection and MR (d), ADC-map
from DW-MR (e), Ktrans parameter map derived from DCE-MR within
the GTV (f). FDG-PET and CT were acquired in PET/CT scanner, all
other datasets were acquired in integrated PET/MR scanner.
advanced multimodal imaging methods as well as accordant image processing
algorithms may be of high potential for improving RT outcome.
Both magnetic resonance imaging (MRI) and positron emission tomography
(PET) are valuable imaging modalities for complementing the CT acquired
for treatment planning with additional anatomical and functional information.
In MR imaging, anatomical, as well as functional imaging, such as diffusion
weighted MR (DW-MR) and dynamic contrast enhanced MR (DCE-MR), are
promising [14–16]. PET tracers with potential benefit for RT are the glucose
analog [18F]-fluorodeoxyglucose (FDG) and dedicated hypoxia tracers such as
[18F]-fluoromisonidazole (FMISO) [17–19] (cf. Section 3.1). To obtain a visual
impression of the different imaging modalities and methods, Figure 1.2 provides
exemplary slices of imaging data of a HNC patient.
PET and MR data may be beneficial in various steps of the RT workflow. On
the one hand, it is expected that these datasets will improve the accuracy of
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tumor volume delineation, which in actual clinical practice is often based on the
planning CT only. For some tumor entities, the usage of FDG-PET or anatom-
ical MR images for tumor volume delineation in addition to the CT is already
standard of care. As an example, anatomical MRI is used to support the de-
lineation of meningiomas [20], and FDG-PET the delineation of target volumes
in non-small cell lung cancer [21]. Moreover, biological differences of tumors as
revealed by functional imaging are currently investigated as explanation for het-
erogeneous treatment response. PET- and MR-based functional imaging data
may be used to stratify patients and individualize treatment, hopefully resulting
in increased treatment response rates and lower toxicities. In this context, one
may switch from the paradigma of a homogeneous tumor dose to the adaption
of radiation dose according to local biological characteristics of the tumor. Such
biological treatment individualization based on functional imaging is currently
evaluated in clinical studies [22–24].
Recently, combined PET/MRI scanners became available, allowing for the
acquisition of PET and MR data in a single imaging session. This may facilitate
the integration of PET and MR information into RT [25]. However, to fully
exploit the potential of this modality, adequate image processing algorithms
have to be developed. This thesis focuses on the development and evaluation
of algorithms for the spatial registration of PET/MR data to the planning CT
and automatic PET/MR-based co-segmentation to standardize tumor volume
delineation. In addition, an analysis of functional PET and MR imaging datasets
for complementarity is performed. It is intended to provide a basis for the
integration of multimodal imaging data into RT and as a step towards biological
treatment individualization.
5

2 Objectives and outline of the thesis
This thesis consists of three parts, each dealing with one aspect concerning the
integration of combined PET/MR into RT treatment planning. The studies
were performed on image datasets of HNC patients, but the methodology could
in general also be extended to other tumor sites. Image processing algorithms
were implemented in C++ with the usage of the libraries ITK (Insight Segmen-
tation and Registration Toolkit, www.itk.org) and VTK (Visualization Toolkit,
www.vtk.org). In the following, an overview of the performed studies is pro-
vided.
• Part I (Chapter 4) deals with the development of an algorithm for the
deformable registration of MR and CT datasets in the HN region. The
motivation of this study was to enable the integration of PET/MR-derived
information into RT treatment planning (cf. Section 3.3.2). Previous lit-
erature addressing such multimodal deformable registration methods were
rare, especially for the HN region no thoroughly evaluated algorithm was
available (cf. Section 4.1). Thus, the objective of this project was to de-
velop and evaluate an algorithm with adequate accuracy for RT purposes.
Registration methods with a B-spline parametrized transform were con-
sidered, using a metric composed of a mutual information based similarity
measure and a regularization term. Quantitative measures were introduced
for a thorough evaluation of registration accuracy.
• Part II (Chapter 5) For a high-precision RT treatment, an accurate tu-
mor volume delineation is essential. For this purpose, the combination of
information from PET and MR datasets may be highly beneficial. More-
over, compared to a purely manual delineation of the tumor, an automatic
algorithm may be valuable for standardization of this task. Thus, an al-
gorithm for segmenting tumor regions by simultaneously considering infor-
mation from FDG-PET and anatomical T2-weighted MRI was developed.
The algorithm contains both connected threshold-based and model-based
segmentation approaches (cf. Section 3.3.3). PET information is used to
inform MR segmentation, which is intrinsically difficult due to the lack of
a standard intensity scale in MRI. The algorithm was quantitatively eval-
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uated against manual contours from three different radiation oncologists,
by comparing the variability between algorithm and each observer to the
variability between the observers.
• Part III (Chapter 6) Tumor characterization based on functional PET
and MR data might be valuable for biologically individualized RT. For an
effective integration of the various available functional datasets into RT, it
is interesting to evaluate if these datasets are completely complementary
or partially redundant (cf. Section 3.3.4). As a first step for address-
ing this question we performed a pairwise correlation analysis of functional
multi-parametric PET and MR data, comprising FDG-PET, FMISO-PET,
DW-MR, DCE-MR datasets. This work extends previous studies, which
performed such analysis on a limited set of functional imaging information
(cf. Section 6.1). The objective of the study was to quantify the level of
correlation between the available functional datasets, as well as the vari-
ability between patients. It is intended as an hypothesis generating pilot
study for further analysis in this field.
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3 Scientific background
3.1 Physics of MR and PET imaging and RT-specific
requirements
3.1.1 Magnetic resonance imaging
In the following, a short overview of the basics of MR imaging is provided. For
further details, the reader is referred to MR standard literature such as [26,27].
MR imaging is based on atomic nuclei with non-zero spin S, which are as-
sociated with a non-vanishing magnetic moment µ = γS. The proportionality
constant γ is the nucleus-specific gyromagnetic ratio. Clinical imaging is typ-
ically based on hydrogen nuclei (i.e. protons), which possess a spin quantum
number of 1/2. Proton-based MRI is of advantage due to the natural abundance
of hydrogen in the body and the high proton gyromagnetic ratio.
In the MR tomograph, a high static magnetic field B0 is created by supercon-
ducting coils, with a typical magnitude of 1.5T or 3T for clinical systems. As a
consequence, nuclear spins in the tomograph precess around the field direction
with the Larmor frequency ωL = γB0. Each proton spin can either be oriented
parallel or antiparallel to the magnetic field, with the associated potential en-
ergy E = −µB0 yielding E = −12γ~B0 and E = +12γ~B0, respectively. In
thermodynamic equilibrium, these energy levels are populated according to the
Boltzmann distribution, with an occupation surplus of the more favorable par-
allel orientation of about 1/10 000 for 3T systems at room temperature. This
leads to a longitudinal macroscopic magnetization parallel to the magnetic field.
By applying a radiofrequency (RF) pulse of resonant frequency ωHF = ωL per-
pendicular toB0, the macroscopic magnetization is tilted towards the transverse
plane. The resulting transversal magnetization leads to the induction of an al-
ternating voltage to receiver coils, which constitutes the measured signal of the
imaging system. Without further disturbance, a relaxation of the spins back
into the thermodynamic equilibrium occurs.
There are two physical mechanisms of relaxation. The first, the longitudinal
relaxation, causes the longitudinal magnetization to return to equilibrium. This
relaxation mechanism is associated with an energy transfer to the surrounding.
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The time period until the equilibrium magnetization is reached to a factor of
1/e is called longitudinal relaxation time T1. The second relaxation mechanism
is the transversal relaxation with the associated transversal relaxation time T2.
The underlying mechanism is caused by spin-spin interactions, resulting in a
dephasing of the spins, and therefore the decay of transversal magnetization.
Both T1 and T2 differ locally within heterogeneous objects.
Spatial encoding is realized by superimposing the static magnetic field B0
with linear magnetic field gradients, which are produced by dedicated gradient
coils within the MR tomograph. These gradients lead to a spatial variation of
Larmor frequencies within the measured object. For three-dimensional spatial
encoding, image gradients are applied in the three orthogonal directions during
the imaging process.
Contrast in anatomical MR images is determined by tissue-dependent differ-
ences in the physical properties influencing MR signals, i.e. the relaxation times
T1 and T2, and the proton density ρ. In addition to anatomical imaging, also
functional imaging techniques are available, revealing information about physi-
cal and physiological parameters rather than anatomical information.
In the following, types of MR images and potential RT-related fields of appli-
cation are outlined.
• Anatomical MR images provide superior soft tissue contrast compared
to CT acquisitions, and may thus facilitate tumor delineation, and pos-
sibly also the delineation of OARs, for RT treatment planning. Another
advantage of MR compared to CT is the reduced extent of dental-inlay
artifacts [28]. A wide variety of different image contrasts can be obtained
by using different MR sequences. Depending on which of the physical
contrast-influencing parameters prevails in the acquired image, the image
is termed T1-weighted, T2-weighted, or proton density (ρ)-weighted.
• Diffusion weighted MR (DW-MR) is a functional imaging technique
allowing for the quantification of the diffusion of water molecules in tis-
sue. For diffusion weighting, an additional gradient followed by a reversing
gradient of the same magnitude and duration is applied between the RF
excitation and signal collection. For stationary spins this gradient pair has
no effect, whereas for diffusing spins dephasing occurs in an extent related
to the local diffusion coefficient. Since DW-MR images are highly sensitive
to motion, rapid image acquisition is necessary. This is typically realized
by using echo-planar imaging (EPI) sequences. From the acquisition of
images with different b-values, i.e. different strengths of diffusion weight-
ing, a physical parameter map containing apparent diffusion coefficients
10
3.1 Physics of MR and PET imaging and RT-specific requirements
(ADCs) can be derived (cf. Section 3.3.4). ADCs represent the effective
water diffusion coefficients, being influenced by the biological environment
such as membranes, and can be related to cellular density [29]. ADC maps
derived from DW-MRI have been found to be of value for the staging of
lymph nodes [30], as well as for prognosis of RT outcome [14].
• Dynamic contrast-enhanced MR (DCE-MR) is a functional imag-
ing technique based on the injection of an MR contrast agent, such as
the Gadolinium (Gd) chelate Gd-DTPA. Since Gd is paramagnetic, it
causes a decrease of T1 relaxation times in its surrounding, resulting in a
concentration-dependent signal increase in T1-weighted images. In DCE-
MR imaging, a series of T1-weighted MR images are acquired, from which
the dynamics of the distribution of the contrast agent in blood pool and
tissue can be determined. By fitting the resulting signal time curves with
compartment models, parameter maps revealing a quantitative description
of microvasculature properties can be derived (cf. Section 3.3.4). Char-
acterization of the deficient vasculature of tumors may yield valuable in-
formation for RT. Compartmental analysis of DCE-MRI has proven to
provide parameters associated with locoregional control after RT [15,16].
Compared to MR images acquired for diagnostic purposes, MR images for RT
may have special requirements. Diagnostic images are often acquired with two-
dimensional sequences, in which imaging data is collected slice-by-slice. These
images are usually characterized by a high resolution in-plane, and a low reso-
lution in slice-encoding direction. Three-dimensional imaging sequences, which
enable a high resolution in all three dimensions, may be more adequate for
tumor volume delineation. A further difficulty may arise due to geometrical
inaccuracies associated with MR imaging. Such inaccuracies can arise due to
inhomogeneities in the static field B0, due to deviations in the linearity of gra-
dient fields, or due to susceptibility or chemical shift artifacts. For anatomical
sequences and field strengths in current clinical scanners these inaccuracies may
be negligible [31, 32], whereas for EPI-based images, such as DW-MR images,
geometrical distortions may hamper usage in RT without an adequate distor-
tion correction scheme [33]. Another difficulty, especially for image processing
algorithms, may be caused by MR signal intensity inhomogeneities, caused by lo-
cally differing receiver coil sensitivities or inhomogeneous RF excitations [34,35].
For facilitating the integration of MRI into the RT treatment planning process,
the possibility of acquiring MR images in RT-specific position is being evalu-
ated [28,36].
11
3 Scientific background
3.1.2 Positron emission tomography
PET is a functional imaging technique, which allows to visualize metabolic
processes in the body. For image acquisition, dedicated tracers, i.e. specific
molecules labeled with positron emitting radioisotopes, are injected into the pa-
tient. Positrons originating from the radioactive decay annihilate after a short
free path with an electron in the tissue. As a result, two 511 keV photons are
emitted under an angle of approximately 180 degrees. For detecting these pho-
tons, the PET scanner is equipped with a ring of independent detectors. Photon
detection allows for the reconstruction of the three-dimensional tracer distribu-
tion within the patient. For reconstruction, each coincidence detection, i.e. each
detection of two photons within a pre-defined short time interval, is attributed
to an annihilation event on the line connecting the two involved detectors. In
modern PET systems, iterative reconstruction algorithms are used, such as the
ordered subset expectation maximization (OSEM) algorithm.
Different PET tracers exist with which different medical questions can be
addressed. The overall molecular structure of the PET tracer determines its
distribution within the patient and potential involvement in biological pathways.
An important physical property for the choice of the radioactive isotope is its
half life. Moreover, the distribution of the kinetic energies of emitted positron
is of relevance, since higher positron energies translate into longer mean free
path lengths before annihilation, therefore restricting spatial resolution of PET
images.
Two PET tracers which are of interest for RT are described in the following.
The radioactive isotope for both tracers is 18F, which has a half life of 110min.
• FDG Compared to normal cells, tumor cells show an increased amount
of glycolysis. This can be both in the case of deprivation of oxygen (Pas-
teur effect) [37], and under normal oxygenated conditions (Warburg ef-
fect) [38, 39]. Glucose metabolism can be monitored using the tracer and
glucose analog [18F]-fluorodeoxyglucose (FDG), which differs from glucose
by the replacement of one hydroxyl group by the positron emitter 18F.
FDG-PET can be of value in RT in the field of tumor volume delin-
eation and lymph node staging [40]. Furthermore, the metabolic tumor
volume (MTV) derived from FDG-PET, as well as the total lesion glycol-
ysis (TLG) and the SUVmax have been found to be related to treatment
outcome [17,41].
• FMISO The irregular growth of tumors is associated with a deficient mi-
crovasculature, due to which the supply of tumor cells with oxygen may
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3.2 Combined PET/MR imaging
be hampered. The state of reduced oxygen levels in tissue is termed hy-
poxia. Hypoxic conditions can be caused by insufficient vascularization
density (chronic hypoxia) or by dynamic changes in perfusion (acute hy-
poxia). Hypoxia has been related with radioresistance [42]. The hypoxic
status of the tumor can be assessed using dedicated tracers such as FMISO,
which selectively binds to macromolecules in cells with reduced oxygen
level. Static PET protocols typically envisage image acquisition at about
4 hours post injection (p.i.), in the late retention phase [18, 19, 43]. How-
ever, also dynamic scan protocols exist, in which an additional dynamic
scan is acquired during the first minutes p.i. Both static FMISO-PET and
parameters derived from compartmental analysis of dynamic FMISO-PET
(cf. Section 3.3.4) have been related to RT outcome [18,19,43,44].
Today, stand-alone PET scanners are increasingly being replaced by PET/CT
scanners [45]. The additional CT acquired with these combined systems provides
anatomical information which is largely missing in PET images, and can further
be used for CT-based PET attenuation correction (cf. Section 3.2.3).
Clinical PET images show low spatial resolution compared to MR and CT
images (cf. Section 3.3.1), which is approximately 5mm for clinical whole-body
systems [45]. In comparison, the typical grid resolution for RT dose calculation
is 3mm. By the related partial volume effect, dimensions of small tracer-avid
structures may be overestimated, with a simultaneous underestimation of the
related activity. Moreover, PET images are usually characterized by a high
level of noise due to the Poisson statistics of the radioactive decay, and lim-
itations concerning the injected dose and the time interval of data collection.
FMISO-PET images typically show low contrast to noise ratios due to the slow
accumulation of FMISO in the cells combined with a slow clearance from blood
and background [42]. Difficulties for the interpretation of FDG may arise due
to physiological or inflammation-caused accumulation [46].
3.2 Combined PET/MR imaging
Combined PET/MR scanners have recently been developed [47–49], and are
currently commercially available in two designs. A sequential design is provided
by the Philips Ingenuity TF (Philips Healthcare, Hamburg, Germany), in which
the PET and MRI scanners are separate, but the patient can be imaged on
a common rotating bed which is transferred between these scanners. On the
other hand, with the Siemens Biograph mMR (Siemens Healthcare, Erlangen,
Germany) a fully integrated design exists in which the PET detector ring is
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Figure 3.1: Schematic representation of integrated PET/MR scanner. Courtesy of
Siemens Healthcare, Erlangen, Germany.
directly integrated into the MR tomograph. With both designs, intrinsically
registered PET and MR images can be obtained, while the integrated design
additionally allows for the simultaneous acquisition of PET and MR data. The
configuration of a fully integrated PET/MR system, as realized by the Siemens
Biograph mMR, is illustrated in Figure 3.1.
3.2.1 Perspectives for RT
The intrinsic registration provided by combined PET/MR facilitates the com-
parison and combined analysis of PET- and MR-derived data, and may thus
be valuable in different steps of the RT workflow [25, 50]. Figure 3.2 illustrates
a potential RT workflow under exploitation of combined PET/MR data. As
displayed in the left column, PET/MR might be of benefit basically in all steps
in which imaging data is required. The data processing part displayed in the
central column will be referred to in Section 3.3.
PET/MRI might be already of value in the process of diagnosis and staging,
on which the decision of the treatment modality as well as the indication for
a palliative versus a curative treatment is based. Concerning the treatment
modality, RT, eventually combined with chemotherapy, or other treatments like
surgery may be applied.
Given an indication for RT treatment, anatomical MR images, potentially
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Figure 3.2: Potential RT workflow under exploitation of combined PET/MR imaging.
The left column shows potential fields of application for which PET/MR
imaging may be beneficial in the course of RT. The data processing steps
in the central column are explained in detail in Section 3.3. After a given
number N of RT fractions, the response to treatment may be assessed, and
treatment plans potentially adapted. If total number of fractions Ntotal
are applied, the RT treatment is completed. Treatment success is finally
assessed in a later follow-up examination.
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combined with functional PET and MR images could assist in an accurate tumor
volume delineation (cf. Chapter 5). A standardization of this task may be
supported by automatic segmentation algorithms.
Additionally, functional PET and MR images, such as FDG-PET, FMISO-
PET, DW-MR, and DCE-MR may be used as basis for a biological characteri-
zation of the tumor, based on which the planned tumor dose might be locally
adapted (cf. Chapter 6). For this purpose, a pre-defined biologically adapted
dose prescription function (PF) has to be available. The objective of this PF
is to achieve homogeneous control probabilities within the tumor, given the un-
derlying heterogeneous biology.
To transfer this PET/MR-derived information to the planning CT, accurate
image registration is a major prerequisite (cf. Chapter 4). RT treatment plan-
ning can then be performed under consideration of the PET/MR-based tumor
delineation and dose adaptation strategies.
In the course of fractionated RT, additional PET/MR imaging sessions could
help in the assessment of treatment response. For the early response assessment,
functional imaging modalities may be superior to anatomical imaging [51–53].
On the other hand, anatomical imaging can be used to adapt treatment plans
according to interfractional anatomical changes, as for example tumor shrinkage.
Such adaptive RT concepts might increase complication-free tumor control, since
the original plan may lead to underdosages in the tumor or overdosages in OARs
due to the change in patient geometry [54,55].
Finally, after the end of RT, PET/MR can assist in follow-up examinations
[52,56]. These examinations are performed several months after RT, in order to
check if RT treatment was successful or if there is a recurrence of the tumor.
3.2.2 Technical aspects of the fully integrated design
The main challenge in the design of a fully integrated PET/MR scanner is the
minimization of interactions between MRI and PET.
Conventional PET detectors consist of a scintillator such as a lutetium oxy-
orthosilicate (LSO), which convert the 511 keV photons into visible light, and
photomultiplier tubes (PMTs), which subsequently translate the light into an
electrical signal. While the scintillators are suited for operation in an MR to-
mograph, the PMTs are highly sensitive to magnetic fields, since electrons are
deflected from their path between the dynodes by the Lorentz force. Thus,
PET detectors of current PET/MR systems are build of scintillators combined
with magnetically insensitive avalanche photodiodes. These semiconducter-based
diodes have been shown to operate in high magnetic fields up to 9.4 T without
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degradation of performance [57]. As a further point, copper screens are necessary
for shielding PET electronics from gradients and RF pulses.
It was found that the integrated PET hardware of the Siemens Biograph mMR
is competitive to the state-of-the-art photomultiplier tube-based hardware in
PET/CT scanners [48]. In addition, the MR subsystem was found to perform
essentially like a stand-alone system [48, 58]. However, the accuracy of PET
quantification may be reduced in PET/MR compared to PET/CT systems, due
to inaccuracies in MR-based PET attenuation correction [59] (cf. Section 3.2.3).
3.2.3 MR-based PET attenuation correction
Background
The photons created in the annihilation process have to transverse tissue, and
potentially hardware components, before reaching the PET detectors. This leads
to interaction processes via the photoelectric effect and Compton scattering,
causing a decrease of the original photon intensity. The photon attenuation
caused by the transit of a material with position-dependent linear attenuation
coefficient µ(x) is in general described by the exponential law of Lambert-Beer
I = I0 exp
(
−
∫
dxµ(x)
)
, (3.1)
with I0 being the original photon intensity, I remaining intensity, and the in-
tegration is over the photon path which would be followed without interaction
processes. If PET image reconstruction is performed without considering this
attenuation, the true PET activity concentrations will be underestimated. Thus,
to yield correct quantitative PET information, an accordant attenuation correc-
tion has to be performed. For this purpose, the local attenuation coefficients
µ for the photon energy of 511 keV have to be known. These coefficients are
typically derived from additionally acquired images (see below) and provided in
the form of an attenuation map (µ-map), containing these coefficients in a voxel
grid.
In stand-alone PET scanners, attenuation correction is based on a transmis-
sion scan from rotating Ge-68 sources, which, mediated by positron decay, emit
511 keV photons. In this case, attenuation information for the PET emission scan
is readily provided at the appropriate photon energy. For the nowadays more
common PET/CT scanners, an accordant µ-map is derived from the CT image.
Since CT images are acquired with a continuous x-ray spectrum, a conversion
to attenuation coefficients for photon energies of 511 keV has to be performed.
The conversion can be readily performed using a bilinear function [60].
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Object-related attenuation correction in PET/MR systems
Attenuation correction for PET/MR systems is more challenging than for
PET/CT, since there is no simple relation of MR signal intensities to electron
densities. However, different approaches have been developed performing MR-
based PET attenuation correction, which either derive a substitute CT from a
combination of MR images, or derive the µ-map directly.
On the one hand, there are segmentation approaches to derive µ-maps from
MR images. The MR-based segments are intended to represent different tissue
types, to which bulk attenuation coefficients are assigned accordingly. In a
simple approach, fat and soft tissue (i.e. water) segmentations are identified
using a Dixon sequence, and remaining voxels are classified as either lung tissue
or air, or as an intermediate between fat and soft tissue∗ [61, 62]. To improve
the accuracy of this approach, ideally a separate segmentation of bone tissue
should be available. Since compact bone has very short transversal relaxation
times of about 0.4 – 0.5ms [63], they hardly show any signal in conventional MR
sequences, which impedes the discrimination of bone from air. To obtain signal
from bone, ultra-short echo time (UTE) sequences have to be applied [64].
In recent research, also the derivation of CT values on a voxel basis from
the combination of several MR sequences is evaluated. To learn the relation
between such multispectral MR data and CT values, a previous training dataset
consisting of registered images has to be available. Training can be based either
on classification [65, 66], or on regression [67, 68]. Once the training has been
performed and validated, newly acquired sets of the same multispectral MR data
can be readily assigned with CT values, allowing for the derivation of a µ-map
for attenuation correction.
Another approach is to use deformable image registration to transfer image
information from CT acquisitions of different patients to MR data acquired
within the PET/MR imaging session. For this purpose, an anatomical atlas,
consisting matched MR-CT acquisitions from different patients can be used as a
basis [69,70]. The MR images of the atlas can be registered to the newly acquired
MR data, which, due to the additionally available CT atlas data, allows for the
assignment of substitute CT values to the newly acquired MR data.
Hardware-related attenuation correction in integrated designs
Hardware components being introduced into the PET detector’s field of view
(FOV), such as the MR table and RF receiver coils, have to be considered for
∗The commercially available Siemens Biograph mMR (Siemens Healthcare, Erlangen, Germany),
which was used for data acquisition in this work, uses this method for PET attenuation correction
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attenuation correction in integrated PET/MR. For the MR table and rigid stan-
dard RF coils with pre-defined positions, such as standard head coils,
manufacturer-provided µ-maps provided with the imaging software are usually
available. For flexible RF coils with no reproducible positioning, attenuation
correction is not straightforward due to the unknown coil location and geome-
try. Thus, these coils are usually neglected in attenuation correction. However,
techniques have been presented for MR-based position determination of flexible
coils, demonstrating that their attenuation correction is feasible [71].
3.3 Image processing for PET/MR data
For the integration of PET/MR data into RT treatment planning adequate
image processing algorithms are mandatory. In the following, some of the asso-
ciated challenges with focus on methods and algorithms which are of relevance
for this thesis are described. We begin with a short mathematical description of
medical images.
3.3.1 Characteristics of medical images
Description of medical images
A continuous image Ic is a function mapping from a spatial domain Ωc ⊂ Rn, n ∈
N+, to a value domain W ⊂ R
Ic : Ωc 7→ W
x 7→ Ic(x).
(3.2)
By means of the image acquisition and reconstruction process, digital medical
images are discretized in the spatial domain (sampling). The images can be
spatially described by a regular grid Γδ with lattice constant δ = (δ1, δ2, . . . , δn).
Image data is then provided in the discrete domain
Ω = Ωc ∩ Γδ, (3.3)
i.e.
I : Ω 7→ W
x 7→ I(x), (3.4)
cf. Figure 3.3. The grid elements are termed pixels (picture elements), or,
especially in the case n = 3, voxels (volume elements). The dimension of medical
images from image modalities such as CT, MR and PET is usually n = 3.
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voxel centers
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Figure 3.3: Schematic representation of a two-dimensional image. δ = (δ1, δ2) and
o = (o1, o2) denote voxel size and image origin, respectively.
The term voxel size describes the spatial extent of the voxels in each of the
n spatial dimensions, which is identical with the lattice constant δ. Due to the
specific image acquisition process, sampling densities, and resulting voxel sizes,
are often anisotropic. Medical images are assigned to an absolute coordinate
system. The image grid is fully described by the position of the image origin in
the coordinate system, the number of voxels in each dimension, and the voxel
size (cf. Figure 3.3).
Image data consists of the image intensities assigned to the center of each
voxel. In digital images, intensities are also discretized (quantization) and de-
fined within a value domainW . Data between voxel centers can be estimated by
an interpolation method, such as linear, B-spline, or Lanczos interpolation [72].
Physical limitations and measures of image quality
The quality of medical images is determined by several factors. One such factor
is the spatial resolution, denoting the minimum distance at which the imaging
system is still able to depict two subject points as separate. Spatial resolution
is related to the point spread function (PSF) of the imaging system, i.e. the
response of the system to a single point stimulus. One factor influencing reso-
lution in PET and CT imaging is the finite spatial extent of the detectors. For
PET imaging, additional factors are caused by the underlying physics, such as
the finite range of emitted positrons before annihilation, and deviations from
the collinearity of the photon pairs created in the annihilation process. With
respect to CT imaging, an additional factor influencing resolution is the finite
focus size of the electrons reaching the anode in the X-ray source. In MRI,
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spatial resolution in slice encoding direction is determined by the combination
of gradient strength and width of the RF pulse spectrum. On the other hand,
the finite extent of the k-space FOV is a limiting factor for the resolution in
directions which are spatially resolved by frequency and phase encoding.
Image noise is an additional factor limiting image quality, and is usually
present as random intensity fluctuations of zero mean. In case of a Gaussian
noise distribution, the noise level can be quantified by the associated standard
deviation σ. There are different origins of noise. In PET imaging, the number
of positrons decaying in a fixed time interval is described by the discrete Poisson
probability distribution, which has the general form
Pλ(k) =
λk
k! exp(−λ), (3.5)
with k the dependent variable (i.e. the number of decays per time interval), and
the parameter λ being the mean of the distribution. Similarly, in CT imaging,
the number of photons being emitted from the X-ray source per time interval is
Poisson distributed. For high values of λ, the Poisson distribution resembles a
Gaussian distribution with σ2 = λ. An additional source of noise in PET and
CT imaging is the thermal noise of detectors and electronics. In MR imaging,
noise originates from the thermal noise of the measured object, the receiver coils
and electronics.
For the characterization of image quality, the noise level relative to the abso-
lute measured signal S is of interest. For Gaussian noise, signal to noise ratios
(SNRs) can be defined as
SNR = S
σ
. (3.6)
If multiple acquisitions with identical acquisition and reconstruction parameters
are available, SNRs can be determined on a voxel-by-voxel level, with S and
σ given as the average voxel signal and standard deviation of the acquisitions,
respectively. Since this approach requires many acquisitions for statistically
reliable results, SNR is in practice usually determined from a single acquisition
with evaluating signal statistics on two separate regions of interest (ROIs). The
mean signal is evaluated in a ROI placed in the (homogeneous) tissue of interest,
whereas the noise is quantified by the standard deviation within a ROI placed in
the image background. A requirement for this approach is, however, a spatially
homogeneous noise distribution.
Object detection depends on the object-to-background contrast as well as the
noise level. Similar to the definition of the SNR, this can be accounted for by
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the definition of a contrast to noise ratio (CNR)
CNR = O −B
σ
, (3.7)
with O and B being the mean ROI-based object and background intensities,
respectively.
3.3.2 Registration methods for integrating PET/MR into RT treatment
planning
For calculation of dose distributions within the RT planning process, electron
density information of the patient is required. To date, this information is
provided only by a dedicated RT planning CT (cf. Section 1).
As pointed out in in Section 3.2.3 with respect to MR-based PET attenuation
correction, there are attempts in recent research to derive electron density infor-
mation directly from MR images. If electron densities could be derived with a
sufficient accuracy using these approaches, RT planning based on PET/MR ac-
quisitions only would be possible [68,70]. However, since this remains an area of
research, a dedicated planning CT is still necessary. To integrate the PET/MR
data, which is routinely acquired without a dedicated patient positioning sys-
tem, into the planning process, the spatial transformation between PET/MR
and CT dataset has to be found. Estimations of this spatial transformation can
be derived by means of image registration algorithms.
Image registration algorithms
Let Ir and Is be two images being defined in the spatial domains Ωr ⊂ Rn and
Ωs ⊂ Rm, with n,m ∈ N+, respectively,
Ir : Ωr 7→ Wr
x 7→ Ir(x)
Is : Ωs 7→ Ws
x˜ 7→ Is(x˜)
(3.8)
with some spatial correspondence. The objective of image registration is then
to find the transformation
T : Ωr 7→ Rm
T (x) = x˜
(3.9)
mapping corresponding positions of the images (cf. Figure 3.4). With this
transformation, Is(T (x) ) yields an image with information provided from Is
which is spatially aligned to Ir. Ir and Is are therefore also denoted as reference
and source image, respectively.
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Figure 3.4: Schematic representation of the image registration problem in two dimen-
sions. The input of an registration algorithm are two images with some
spatial correspondence. Is, the source image is defined in coordinates
x = (x1, x2), whereas Ir, the reference image, is defined in coordinates
x˜ = (x˜1, x˜2). The objective of image registration is to find the best esti-
mate for the transform T (x) = x˜, which maps Is to Ir.
In a rigid registration, the transformation is limited to translation and rotation.
T can then be defined as
Trigid(x) = Rαx+ c, (3.10)
where Rα is the rotation matrix and c the translation vector. In three dimen-
sions, this transformation consists of six degrees of freedom in total, defined by
three rotation angles α = (α1, α2, α3) and three translational coordinates. The
associated parameter vector, containing the parameters to be optimized in the
registration process, is thus given by µ = (α, c).
If medical images from the same patient acquired in different scanners have
to be registered, rigid registration can yield good results in areas where no, or
only small, deformations are expected, such as the brain. However, for other
anatomical sites a rigid registration may not yield satisfactory results. As an
example, for acquisitions in the head and neck region, a deformable registration
(DR) may be required to map differences in the bending of the cervical spine
and deformations of soft tissue.
One approach for DR is the representation of the transform as a weighted sum
of smooth basis functions. Such a parameterization-based approach will be de-
scribed in more detail in the following. Examples for non-parametric approaches
are optical flow based methods [73].
One possible parametrization of the transform can be realized using cubic B-
splines, which have the advantage of being basis functions with local support.
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Figure 3.5: Illustration of the parametrization of a one-dimensional transform with
cubic B-splines. B-spline control points are located at integer positions,
which corresponds to a control point spacing of d = 1 (cf. Equation 3.12).
The red curve is the final transformation, which is the sum of the B-splines
centered at the control points (other colors).
With this parametrization, the transform can in three dimensions be defined as
Tbspline(x) = x+
∑
xk∈Nx
pkβ
(3) (a) , (3.11)
with ai =
(x− xk)i
di
for i in {1, 2, 3}. (3.12)
Here, xk are control points, building up a regular grid. d is the control point
spacing, which determines the flexibility of the transform. β(3) the cubic multidi-
mensional B-spline polynomial, given by the tensor product β(3)(x) = β(3)(x1)⊗
β(3)(x2)⊗ β(3)(x3) of the one-dimensional cubic B-spline
β(3)(x) =

1
6(4− 6x2 + 3|x|3), 0 ≤ |x| ≤ 1
1
6(2− |x|3), 1 ≤ |x| ≤ 2
0, 2 ≤ |x| .
(3.13)
Nx is the set of all control points within the compact support of the B-spline
at x. pk are coefficients which act as registration parameters. Thus, the pa-
rameter vector of this transform is given by µ = (p1,p2, . . . ,pN), with N being
the total number of control points. A schematic illustration of the B-spline
parametrization is provided in Figure 3.5.
After the definition of a parametrized transform, the registration problem can
be formulated as an optimization problem within which a pre-defined metric
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M, providing a measure of registration quality, is minimized with respect to the
transform parameters µ,
µˆ = argmin
µ
M(µ; Ir, Is). (3.14)
M can generally be defined by a combination of a measure of image similarity
S, which depends on both the images and the transform parameters, and a
regularization term R, depending on the transformation parameters only,
M(T ; Ir, Is) = −S(T ; Ir, Is) + γR(T ). (3.15)
For the determination of S interpolation of the source image data is necessary.
A simple image similarity measure for monomodal registration is the sum of
squared differences (SSD),
SSSD(T ; Ir, Is) = 1|Ωr|
∑
x∈Ωr
(Ir(x)− Is(T (x)))2 , (3.16)
where |Ωr| is the number of voxels contained in Ω and the summation is over all
voxel centers. From the definition follows that the SSD becomes lower if image
intensity values show a better spatial agreement.
For images from different modalities, as CT compared to MR, no simple re-
lationship between image intensities exists. Thus, the similarity of the images
given specific transform parameters has to be described in a more general, sta-
tistical way. Such a statistical measure is provided by the mutual information
(MI), which has been introduced to image processing by Collignon et al. [74]
and Viola and Wells [75]. This measure can be defined as
SMI(T ; Ir, Is) =
∑
r,s
p(r, s) log
(
p(r, s)
p(r)p(s)
)
, (3.17)
where r and s are the (binned) voxel values of the images Ir and Is. p(r)
and p(s) are marginal probabilities of r and s, respectively, and p(r, s) their
joint probability. From the definition in Equation 3.17 it can be inferred that
MI measures the distance between the joint probability distribution of the two
images, p(r, s), and the joint distribution one would obtain if the two images
were completely independent, i.e. p(r)p(s). The definition of MI is related to the
Shannon entropy from information theory [76]. Equation 3.17 can be rewritten
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Figure 3.6: Joint histogram of an MR image of the head and neck with itself. From
left to right: perfect overlap, translation by one voxel, translation by two
voxels. Corresponding joint entropies EJ are provided in the plots. A
joint histogram reveals the probabilities of co-occurrence of binned voxel
values. With inreasing misregistration the joint histogram disperses and
the joint entropy, which can be interpreted as a measure of this dispersion,
increases.
as
SMI(T ; Ir, Is) =−
∑
s
p(s) log p(s)︸ ︷︷ ︸
Es
+(−∑
r
p(r) log p(r)︸ ︷︷ ︸
Er
) (3.18)
− (−∑
r,s
p(r, s) log p(r, s)︸ ︷︷ ︸
EJ
). (3.19)
Es and Er are the Shannon entropy of the first and second image, respectively,
whereas EJ is their joint entropy. An illustration of joint entropy is provided in
Figure 3.6.
As regularization term R, a common choice is the bending energy penalty
(BEP), being in three dimensions defined as
RBEP(T ) = 1|Ωr|
∑
x˜∈Ωr
3∑
i=1
3∑
j=1
(
∂2T (x˜)
∂xi∂xj
)2
, (3.20)
with the summation being performed over the voxel centers. This term is moti-
vated by the two-dimensional bending energy of a thin plate of metal [77], and
favors smooth transformations.
The registration parameters µ are then optimized with respect to M. Gen-
erally,M is a complex function with multiple local minima. For optimization,
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various algorithms are available in numerical literature. A comparison of differ-
ent optimization strategies applied for image registration is provided in [78].
3.3.3 Dedicated tumor segmentation strategies
Image segmentation is the task of partitioning images into multiple segments
according to the underlying content. For RT, automatic segmentation strategies
for the distinction of tumor and non-tumor regions are of particular interest. As
outlined in Section 3.1, combined PET/MR data may be beneficial for accurate
tumor volume delineation.
A variety of segmentation algorithms already exist, which can be used as a
basis for segmenting PET/MR data. Some algorithms use image intensities
directly as input for segmentation, whereas others operate on image gradients
or edges. On the other hand, segmentation algorithms can be discriminated by
how much they are influenced by the image data and how much they impose a
specific model on the segmentation. Model-driven algorithms can enforce closed
and smooth boundaries irrespective of the image content.
Concerning PET segmentation, different methods have been published in
literature. Comprehensive reviews of these methods are provided in [79, 80].
However, literature addressing the segmentation of anatomical MR images has
mainly been focused on brain tumors [81, 82]. In the following, segmentation
algorithms applied within this thesis are discussed.
Threshold-based segmentation
The basic threshold segmentation algorithm classifies each voxel according to its
data value in a purely data-driven approach. In this concept, the segmentation
of an object from background is in general based on the definition of a lower
threshold L and an upper threshold U , setting the classification criterion of voxel
i with intensity Ii to
mi =
1 if L < Ii < U0 else (3.21)
with 1 and 0 denoting the object and background segments, respectively. A com-
mon method for tumor segmentation based on FDG-PET is a relative threshold
segmentation with the lower threshold set to 40% of the maximum SUV of the
tumor [21].
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Figure 3.7: Illustrations of the threshold level set algorithm. (a) Level set segmenta-
tion is based on the evolution of a level set function φ(x). The segmen-
tation boundary Γ is defined at each time point by Γ = {x|φ(x) = 0}.
(b) The propagation function D(x) used for the threshold level set algo-
rithm is determined by a lower threshold L and an upper threshold U , see
Equation 3.29. Reproduced from the ITK manual [83].
Level set segmentation
The level set method belongs to the implicit active contours/surfaces algorithms
within the model-driven segmentation methods. Within these methods, the
segmentation boundary is implicitly represented by a function in the space in
which the boundary is embedded. A boundary Γ of n − 1 dimensions can be
defined by a auxiliary level set function φ(x) of n variables based on the relation
Γ = {x|φ(x) = 0} (3.22)
(cf. Figure 3.7 a). Γ is termed the zero level set. An adequate function for φ(x)
is then, for example, the signed distance to the represented boundary. For vol-
umetric medical images, segmentation boundaries are usually two-dimensional
surfaces, as n equals 3.
During the segmentation process, the level set function, and thus also Γ, is
evolved in time. The time evolution is governed by a differential equation, which
couples the speed of deformation to the image data. Many variants of this basic
concept have been proposed [84]. The generic form of the level set equation
can be derived by building the total differential of the time-dependent defining
equation
φ(x(t), t) = 0, (3.23)
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which yields
∂φ
∂t
+∇φ · ∂x
∂t
= 0. (3.24)
To impose a curve evolution in the normal direction, it can be forced that
∂x
∂t
= FN , (3.25)
where
N = ∇φ|∇φ| (3.26)
is the normal to the level set curve. F determines how fast the curve evolves lo-
cally, and is therefore termed speed function. With this condition, the boundary
Γ thus evolves in the normal direction with the local speed determined by F .
With Equations 3.24 to 3.26, the generic partial differential equation (PDE)
[85] of the level set segmentation is obtained
∂φ
∂t
= −F |∇φ| . (3.27)
The speed function F can in general be splitted into a data-driven term D,
and a model-driven termM
F = αD + βM, (3.28)
with respective weights α and β, respectively. D can either be based on original
image intensities, or on gradient or edge information.
For threshold level set segmentation, the data driven term depends on the
position vector only, and can be defined as
D(x) =
I(x)− L if I(x) < (U − L)/2 + LU − I(x) otherwise (3.29)
with an upper threshold U and a lower threshold L (cf. Figure 3.7 b). The
feature image I(x) can be either the original image to be segmented or some
kind of preprocessed version thereof.
The model-driven termM is independent on the image data, and can be used
to provide a regularization to the segmentation. A common choice is to set
this term equal to the curvature κ = ∇ · ∇φ|∇φ| , imposing a smooth segmentation
boundary.
Equation 3.27 in combination with an initial level set function φ(x, t = 0)
can be considered as initial value problem. φ(x, t = 0) can be provided by the
signed distance of a contour obtained with some preliminary rough segmentation
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approach. The level set function is subsequently evolved in time by numerical
integration of a discretized form of Equation 3.27 until a pre-defined convergence
criterion is achieved. The segmentation result is given by the final zero level set.
3.3.4 Analysis of physical properties in multi-parametric PET/MR data
PET/MR scanners allow for the acquisition of various types of functional images
(cf. Section 3.1), which may allow for biologically adapted treatments. Potential
applications are RT treatment individualization, the assessment of chemotherapy
efficacy, and the application of targeted agents, such as hypoxia-sensitizing or
antiangiogenic drugs [86,87].
For RT treatment adaption, a dose PF has to be found, which ideally modu-
lates the locally prescribed tumor dose in a way that equal control probabilities
within the heterogeneous tumor tissue are obtained, thus compensating for dif-
ferent biological microenvironments. However, the definition of an adequate PF
is not straightforward. Statistical analysis of functional imaging datasets and
their relation to treatment outcome could provide evidence for the design of
individually adapted treatment approaches [13].
Derivation of (semi-)quantitative parameter maps from functional images
Functional imaging data may be preprocessed to extract quantitative parame-
ters, ideally with known physical and physiological meaning. Fit parameters
from voxel-by-voxel analysis of the imaging data can be stored in parame-
ter maps. Advantages of deriving quantitative parameters are increased inter-
patient comparability as well as the dimensionality reduction of acquisitions
with various time frames such as dynamic FMISO-PET and DCE-MRI. In the
following, PET- and MR-based parameter maps are described.
• The comparability of FDG-PET activity concentrations between differ-
ent patients can be enhanced by a normalization with respect to patient
weight and decay-corrected injected activity. This normalization leads to
standardized uptake values (SUVs) of the form
SUV = cA
A0/mpat
, (3.30)
with cA being the local tracer activity concentration as revealed by the
imaging data, A0 the decay-corrected injected activity, and mpat the mass
of the patient. However, SUVs are not fully quantitative, since they are
influenced by factors such as body composition, and the plasma glucose
level [88].
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• In static FMISO-PET images, tumor voxel activities are usually normal-
ized by the background signal in a deep neck muscle [19]. After defining a
muscle ROI ΩM, tumor to background ratios (TBRs) are given as
TBR = cA
cA,ΩM
. (3.31)
where cA,ΩM is the mean activity concentration in ΩM.
• From dynamic FMISO-PET, quantitative parameter maps can be de-
rived by compartmental modeling (cf. Figure 3.8 a). It has been proposed
to fit measured time-activity data on a voxel level with a two-compartment
model including tracer retention [89]. Compartmental parameters derived
from dynamic FMISO-PET may be superior for the characterization of hy-
poxia than imaging information from a single PET time frame, since they
might also reveal severe hypoxia (existing along with necrotic areas) which
is potentially missed in a static-only acquisition [44].
• Also DCE-MR data can be fitted by compartment models to yield quan-
titative parameter maps of physiological meaning (cf. Figure 3.8 b). Dif-
ferent models are available in literature, such as the Brix [91], extended
Tofts [90], and the two-compartment exchange model (2CXM) [92]. In
this work, the extended Tofts model is applied, yielding parameter maps
of the volume fraction of the extracellular-extravascular space (EES), ve,
the volume fraction of the blood, vp, and the volume transfer rate from
blood plasma to the EES, Ktrans.
• In DW-MR, ADC maps can be derived from the images acquired with
different b-values, i.e. different degrees of diffusion weighting. The relation
between signals S and b-values is usually modeled by a mono-exponential
function [29]
S = S0 exp (−b · ADC) , (3.32)
where S0 is the signal without diffusion weighting. With Equation 3.32
ADC values can be obtained by fitting lnS over b with a linear model.
Especially for low b-values, microcapillary perfusion may influence the
measured signals. If the measured signal values S are influenced by both
perfusion and diffusion effects, a bi-exponential fit is more adequate [93].
Calculation of ADC maps is typically integrated in manufacturer-provided
software of the MR scanner.
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Figure 3.8: Dynamic functional data (points) derived from individual voxels within
the GTV of a HNC patient, shown along with fits by compartment models
(lines). (a) FMISO-PET activity concentration cA over time, and fit by
two-compartment model [89], for two different voxels (red, green). The
data acquisition protocol consisted of dynamical data collection 0–35min
p.i., and subsequent static scans at 2 h p.i. and 4 h p.i. . The red colored
data is characterized by a high initial peak due to a good vascularization,
as well as missing tracer retention, indicating a non-hypoxic voxel. The
green colored data shows increasing activity in late times, thus indicating
tracer retention due to hypoxic conditions. (b) Signal S from DCE-MR
over time for an exemplary voxel in the GTV of a HNC patient. The fit was
performed with the extended Tofts model [90]. Figures kindly provided
by Urban Simončič.
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Statistical analysis and statistical learning methods
Inter-dependence of two variables, such as pairs of functional image data, can
be examined by means of statistical analysis methods.
With the Pearson product-moment correlation coefficient ρX,Y it can be quan-
tified to which extent two variables X and Y are linearly correlated. ρX,Y is
defined by
ρX,Y =
Cov(X, Y )
Var(X) Var(Y ) (3.33)
= E[(X − E[X])(Y − E[X])]√
E[(X − E[X])2]
√
E[(Y − E[Y ])2]
, (3.34)
where Cov(X, Y ) is the covariance between X and Y , Var(·) is the variance,
and E[·] the expected value of the respective variable.
Values of ρX,Y range between −1 and 1, where −1 and 1 are obtained for
perfect positive and negative linear correlations, respectively. A value of 0 is
obtained for totally uncorrelated variables.
If samples of X and Y are available, sample-based estimates of covariances
and variances yield the expression
r = rxy =
∑n
i=1(xi − x¯)(yi − y¯)√∑n
i=1(xi − x¯)2
√∑n
i=1(yi − y¯)2
, (3.35)
where {xi | i = 1, . . . , n} and {yi | i = 1, . . . , n} are the samples taken from X
and Y , respectively, and x¯ and y¯ are the sample averages.
The Spearman rank correlation coefficient quantifies the degree of monotonic-
ity between to variables, irrespective of the exact form of the relation. This is
achieved by modifying Equation 3.35 by replacing the sample values with their
respective rang rg(·) within the sample
xi → rg(xi), yi → rg(yi). (3.36)
Since the Spearman coefficient describes the general degree of monotonicity, it
has broader scope than the Pearson coefficient. By definition, the Spearman
coefficient is also much less sensitive to outliers.
In addition to the mathematically simple correlation coefficients for pairs of
variables, also more advanced methods for statistical analysis exist, with which
statistical relations between three or more variables can be inferred. Such ma-
chine learning algorithms can be applied to higher-dimensional data.
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For exploratory data analysis without the availability of response variables,
clustering approaches can be applied. These allow for the detection of patterns
in a multidimensional dataset [94].
If categorical response variables (i.e. class labels) are available, classification
can be performed. In general, the purpose of statistical classifiers is to derive a
relationship between the feature vectors and class labels using a training dataset.
The goal of the classification is to predict the class label of feature vectors of an
independent test dataset with a high accuracy [94,95]. Examples for non-linear
classification methods include the support vector machine, the random forest
method and neural networks.
If, on the other hand, the response variable is not categorical but quantitative,
regression instead of classification can be applied to learn the relation between
feature vectors and response variables. Non-linear regression can be performed
with the random forest method, which is also suited for classification purposes.
During the training process of classification as well as regression methods,
the relationship between feature vectors and response variable is learned using
the dedicated training dataset. Since there is a risk of overfitting noisy or un-
representative data, a test dataset has to be available to validate the trained
relationship. As an alternative, cross-validation schemes can be applied.
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4 Deformable registration of PET/MR
Abstract
Background: Combined PET/MRI is highly promising for biologically individ-
ualized radiotherapy (RT). Hence, the purpose of this work was to develop an
accurate and robust registration strategy to integrate combined PET/MR data
into RT treatment planning.
Material and Methods: Eight patient datasets consisting of an FDG PET/CT
and a subsequently acquired PET/MR of the head and neck (HN) region were
available. Registration strategies were developed based on CT and MR data
only, whereas the PET components were fused with the resulting deformation
field. Following a rigid registration, deformable registration was performed with
a transform parametrized by B-splines. Three different optimization metrics
were investigated: global mutual information (GMI), GMI combined with a
bending energy penalty (BEP) for regularization (GMI+BEP) and localized
mutual information with BEP (LMI+BEP). Different quantitative registration
quality measures were developed, including volumetric overlap and mean dis-
tance measures for structures segmented on CT and MR as well as anatomical
landmark distances. Moreover, the local registration quality in the tumor re-
gion was assessed by the Normalized Cross Correlation (NCC) of the two PET
datasets.
Results: LMI+BEP yielded the most robust and accurate registration results.
For GMI, GMI+BEP and LMI+BEP, mean landmark distances (standard devi-
ations) were 23.9 mm (15.5 mm), 4.8 mm (4.0 mm) and 3.0 mm (1.0 mm), and
mean NCC values (standard deviations) were 0.29 (0.29), 0.84 (0.14) and 0.88
(0.06), respectively.
Conclusion: Accurate and robust multimodal deformable image registration of
CT and MR in the HN region can be performed using a B-spline parametrized
transform and LMI+BEP as optimization metric. With this strategy, biologi-
cally individualized RT based on combined PET/MRI in terms of dose painting
is possible.
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4.1 Introduction
Recently, combined imaging of Positron Emission Tomography (PET) and Mag-
netic Resonance Imaging (MRI) has become available [96]. This new imaging
technique allows for the simultaneous acquisition of functional MR and molecu-
lar PET information, resulting in accurately co-registered datasets. As a conse-
quence, integrated PET/MR may be highly beneficial for radiotherapy (RT) in-
dividualization [25]. On the one hand, the molecular, functional and anatomical
information from PET/MR data be can be used in RT treatment planning (RTP)
for improving the precision of tumor volume delineation [79, 97]. Moreover, the
molecular information on tumor physiology, biology, and radioresistance may
serve as a basis for biologically individualized RT in terms of dose painting
(DP) [98,99]. Furthermore, combined PET/MR imaging might be also valuable
for the assessment of treatment response and follow-up after therapy [100].
However, for the integration into RTP, PET/MR data has to be fused with the
Computed Tomography (CT) image generally used for treatment planning. For
an accurate fusion of PET/MR and CT data, the anatomical information of CT
and MR can be used for registration, and the PET component of the PET/MR
can be co-transformed with the resulting deformation field. Due to the different
physical principles of image acquisition, CT and MR do not show a simple
relationship between image intensities. Moreover, to date it is not possible to
acquire combined PET/MR in the head and neck (HN) region with dedicated
RT positioning aids. Therefore a suitable multimodal deformable registration
(DR) algorithm is required. Another potential application of DR of MR and CT
is the attenuation correction of PET/MR data using deformed CT images [70].
Previous strategies for the DR of CT and MR images have been published
for different anatomical sites such as liver [101], breast [102] and prostate [103].
For the HN region, the development of DR strategies has so far mainly been
focused on monomodal DR of CT images [104]. Nevertheless, some studies
also investigated DR algorithms for the fusion of multimodal imaging data. In
the study published by Söhn et al, a multimodal DR algorithm based on rigidly
matching local image subvolumes was applied to fuse CT and MR data of the HN
region [105]. Nevertheless, this study was intended as a proof of concept without
quantitative evaluation. Another study applied a different algorithm matching
the bony structures in combination with a linear elastic biomechanical finite
element model for image registration of CT and MR in the HN region [106], and a
landmark-based evaluation for four datasets was provided. A common approach
for multimodal DR is to use an algorithm consisting of a B-spline parametrized
transform and mutual information (MI) as similarity measure [77,107]. However,
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also localized versions of MI have been considered recently, where MI is evaluated
in subregions of the images only [108,109].
In this study, B-spline based algorithms with both global and localized forms
of MI are applied for DR of CT and MR in the HN region and the registration
accuracy is assessed by means of quantitative measures. The aim is to develop
an accurate and robust registration method for potential future integration of
PET/MR image data into RTP.
4.2 Material and Methods
4.2.1 Patient data
Eight patient datasets acquired within a clinical imaging study were available.
Each dataset consists of a PET/CT and subsequently acquired PET/MR, with
the PET-tracer [18F]-Fluorodeoxyglucose (FDG) (cf. Figure 4.5). The mean
injected activity of FDG was 351MBq (range: 320MBq – 388MBq). PET/CT
data were acquired after a mean time of 81min p.i. (range: 76min – 94min)
and PET/MR data after 136min p.i. (range: 120min – 166min). Detailed
information about the patient characteristics is given in Table 4.2.
The PET/CT was acquired without fixation with a Siemens Biograph mCT
(Siemens Healthcare, Knoxville, TN). The CT consisted of a low-dose and con-
trast enhanced acquisition. For PET reconstruction, 3D OSEMwith 2 iterations,
21 subsets and a 3D Gaussian filter of 2mm was used. Approximate voxel sizes
of the CT and the PET images were 0.8×0.8×3.0mm3 and 1.6×1.6×3.0mm3,
respectively.
The PET/MR was acquired without fixation with the Siemens Biograph mMR
(Siemens Healthcare, Erlangen, Germany). The MRI datasets taken into ac-
count for this study were T2-weighted acquisitions using a Short Time Inversion
Recovery (STIR) sequence taken in the transversal direction. For PET recon-
struction, 3D OSEM with 3 iterations and 21 subsets and a 3D Gaussian filter of
3 mm was used. MR attenuation correction was performed based on a segmen-
tation approach on basis of spoiled gradient-echo sequences with DIXON-based
fat-water separation. Approximate voxel sizes of the STIR and the PET images
were 0.7× 0.7× 4.8mm3 and 2.8× 2.8× 2.0mm3, respectively.
4.2.2 Image Registration
Image registration was performed using information from CT and MR only, with
the CT serving as fixed image and the MR serving as moving image. After reg-
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istration, both MR and PET from the PET/MR examination were transformed
to the PET/CT data. Thus, after registration, the CT and the MR as well as
the two PET images were defined in the same coordinate system.
First, a rigid registration (RR) was performed. The resulting transform was
then used for the initialization of the DR methods, where three different strate-
gies were investigated. Since the available datasets had different Fields of View
(FOV), they were cropped after RR in order to cover the same anatomical region.
Both RR and DR were performed with the freely available, open source reg-
istration package elastix [110] which is based on the ITK (Insight Segmentation
and Registration Toolkit, www.itk.org). DR was performed with a three level
multi resolution approach, using only Gaussian smoothing without downsam-
pling. Smoothing scales were chosen as σ = 8.0, 4.0, 1.0 in x and y direction and
σ = 2.0, 1.0, 0.5 in z direction, to account for voxel anisotropy.
For each DR strategy a transform parametrized by B-splines was used [77].
For the optimization of the metric, a stochastic gradient descent optimizer [111]
was applied. In this optimization strategy, a sampler randomly choses a given
number of image positions every iteration for metric estimation.
As similarity measure, firstly MI calculated from samples over the whole image
domain was used, which is referred to as global MI (GMI). Secondly, a localized
version of MI was considered, where the localization is achieved as described
in [108]. Briefly, sampling is constrained to a cubic subregion of the image of
length Lsub, which is chosen randomly in every iteration step from the fixed
image domain. This method is referred to as localized MI (LMI). For regular-
ization of the transform a bending energy penalty (BEP) term was applied [77],
defined as
BEP = 1
P
∑
x˜p
3∑
i=1
3∑
j=1
3∑
k=1
(
∂2Ti(x˜p)
∂xj∂xk
)2
, (4.1)
where x˜p are the voxel positions, and P is the number of voxels. Ti denotes the
ith component of the transform, and x1, x2 and x3 are the coordinates in x, y
and z direction, respectively. The BEP favors a smooth deformation field.
The following combinations were investigated for the registration metricM:
M =

−GMI (GMI)
−GMI + λBEP (GMI+BEP)
−LMI + λBEP (LMI+BEP)
, (4.2)
where λ determines the weight of the regularization with respect to the similarity
measure.
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For some of the free parameters of the DR methods, such as the B-spline
grid spacing, the number of iterations and the number of samples used for met-
ric evaluation during optimization, predetermined parameters were used. The
remaining free parameters, i.e. the number of histogram bins used for MI calcu-
lation, λ, and Lsub, were optimized independently for each DR method according
to the registration quality measures derived from segmentations described below.
The final parameter sets are provided in Table 4.3.
4.2.3 Visual assessment of registration quality
A visual assessment of registration quality was performed based on fusion images
of CT and MR and as well as of two PET images. Moreover, the deformation
fields obtained from the different DR methods were assessed qualitatively by
the corresponding map of Jacobian determinants IJD [112,113]. Jacobian deter-
minant values smaller than 1 are associated with a local volume compression,
values equal to 1 with local volume preservation, and values greater than one
with local volume expansion. Negative values of the Jacobian determinant are
obtained in the presence of foldings, which are unrealistic for medical images.
4.2.4 Quantitative assessment of registration accuracy
Several measures for the determination of registration accuracy were imple-
mented using ITK and VTK (Visualization Toolkit, www.vtk.org). For the
structures skin, carotids, and respiratory tract segmented on CT and MR, both
the Dice Similarity Index (DSI) and mean distances after registration were eval-
uated. As mean distance measures, the Mean Volume Distance (MVD) was
determined for the skin as well as for the respiratory tract structure, whereas
for the carotids the Mean Line Distance (MLD) was evaluated. In addition,
the Non Overlapping Fraction (NOF) of the bony structures segmented from
CT and the spinal canal segmented from the MR image was calculated. More-
over, the mean residual distance (Mean Point Distance, MPD) of anatomical
landmarks defined by two experienced radiation oncologists was evaluated after
registration.
A validation of the local registration accuracy in the tumor region based on the
image information from CT and MR is difficult, since the intra-tumor region can
be of low contrast in these imaging modalities. As the PET images provide local
image information in this region, the registration accuracy in the tumor region
was assessed by Normalised Cross Correlation (NCC) of the fused PET images.
Detailed information about the quantitative registration accuracy measures is
provided in the Section 4.6.
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Figure 4.1: Fusion images after RR and DR for Patient 4. Fusion of the original CT
(grey) and the deformed MR (orange) after RR (A) and after DR with
LMI+BEP (B). Fusion of the PET of the PET/CT (red) and the deformed
PET of the PET/MR (green) after RR (C) and after DR with LMI+BEP
(D).
4.3 Results
4.3.1 Qualitative Evaluation
Fusion images of CT and MR as well as of the PET images are displayed in
Figure 4.1 exemplarily for Patient 4 after both RR and DR with LMI+BEP. The
fusion images after RR showed large remaining misalignments due to different
patient positioning. After DR, a visually good alignment of both the anatomical
and the functional images could be obtained.
Figure 4.2 shows IJD shows and the corresponding deformed MR images ob-
tained by the three DR methods obtained for Patient 1. GMI led to Jacobian
determinant values with high absolute differences to 1, and also foldings were
present. Compared to RR, the corresponding deformed MR was better aligned
to the shown anatomical contours, but unrealistic deformations occurred. The
deformed MR images obtained by the registration strategies that apply a reg-
ularization term (GMI+BEP and LMI+BEP) did not suffer from unrealistic
deformations and corresponding IJD showed only moderate and smooth volume
expansions and compressions. Moreover, also a good alignment to the anatom-
ical contours was achieved.
Figure 4.3 shows axial slices of the original CT and the transformed MR
after RR as well as after DR with LMI+BEP for Patient 2, in addition to
contours defined on basis of the CT image. For the rigidly transformed MR, large
misalignments to the CT contours remained, whereas the DR with LMI+BEP
led to a significant improvement. However, for the skin some misalignments
remained in regions where large local deformations are present.
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Figure 4.2: Map of Jacobian determinants (IJD) and corresponding deformed MR from
different registration methods for Patient 1. Original CT (A), IJD from
DR with GMI (B), GMI+BEP (C) and LMI+BEP (D). Transformed MR
from RR (E), deformed MR from DR with GMI (F), GMI+BEP (G) and
LMI+BEP (H). The structures skin and respiratory tract segmented on
the original CT are shown as red contours.
Figure 4.3: Axial slices of the original CT (A), transformed MR from RR (B) and
from DR with LMI+BEP (C) for Patient 2. Contours of skin (brown),
bones (yellow) and respiratory tract (blue) derived from the original CT
are also shown.
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Table 4.1: Quantitative results of the registration methods as mean (standard devia-
tion) over all patients.
RR GMI GMI+BEP LMI+BEP
DSI skin 0.94 (0.02) 0.97 (0.01) 0.97 (0.00) 0.98 (0.00)
DSI carotids 0.14 (0.16) 0.07 (0.09) 0.37 (0.26) 0.59 (0.18)
DSI respiratory tract 0.39 (0.22) 0.49 (0.31) 0.59 (0.30) 0.76 (0.07)
NOF bone/spinal canal 0.50 (0.24) 0.55 (0.12) 0.72 (0.27) 0.92 (0.06)
NCC PET 0.67 (0.31) 0.29 (0.29) 0.84 (0.14) 0.88 (0.06)
MVD skin (mm) 4.07 (1.58) 1.70 (0.71) 1.75 (0.49) 1.47 (0.44)
MLD carotids (mm) 7.27 (3.17) 15.82 (6.79) 5.41 (5.22) 1.92 (0.61)
MVD respiratory tract (mm) 4.45 (2.47) 5.92 (7.87) 3.92 (5.43) 1.33 (0.46)
MPD landmarks (mm) 6.97 (4.95) 23.86 (15.51) 4.78 (4.02) 2.96 (1.02)
4.3.2 Quantitative Evaluation
Quantitative results for all patients are summarized in Table 4.1 as well as in
Figure 4.4. For GMI, the measures for the skin improved compared to RR,
but unrealistic deformations as shown in Figure 4.2 led to worse quantitative
registration results for other measures. For GMI+BEP, all registration accuracy
measures improved compared to RR. However, considerable variations remained,
showing that the method is not robust with respect to inter-patient variation
between different datasets.
In contrast, LMI+BEP showed a robust behavior and a good registration
accuracy. Residual distances were in the order of half the voxel size of fixed and
moving image in z-direction (voxel size CT: 3.0mm, MR: 4.8mm) (cf. Table 4.1).
Moreover, the NCC of the PET images in the tumor region improved in line with
the registration accuracy measures defined based on CT and MR.
4.4 Discussion
In this work, three different DR strategies for the fusion of CT and MR in the
HN region were evaluated qualitatively and quantitatively, with the purpose
of integrating PET/MR data into RTP. All algorithms used a multi-resolution
approach and a B-spline parametrized transform, whereas the different metrics
GMI, GMI+BEP and LMI+BEP were applied. Compared to RR, using the
metric GMI in most cases resulted in worse registration results in addition to
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unrealistic deformations. In principle, the degree of unrealistic deformations
could be lowered by a smaller B-spline grid spacing, but this would simultane-
ously decrease the degree of freedom of the transform. For DR with GMI+BEP,
registration accuracy improved compared to RR, but a lack of robustness was
observed. Using LMI+BEP as optimization metric, accurate and robust results
were obtained, even for patients with large positioning differences in CT and
MR. Distance quality measures showed that residual distances were in the or-
der of half the voxel size of the CT and MR in z-direction, indicating a high
geometric accuracy.
Due to the small diameter of the carotids, the DSI for this structure can
decrease severly even for small misregistrations. Therefore, the MLD should
provide a better measure of registration accuracy for this structure, showing that
the registration accuracy in the carotid region is similar to the other structures.
In contrast to the other registration methods, for LMI+BEP no outliers were
present apart from the outlier observed for the DSI measure of the carotids (cf.
Figure 4.4). However, since this registration method has been evaluated on a
limited dataset, at least a visual examination of the registration results obtained
with LMI+BEP should be performed for additional datasets.
However, there are also inherent limitations of the algorithm as shown in
Figure 4.3. Since the B-spline parametrization provides only a limited degree
of freedom of the transform, the algorithm is not able to map large local de-
formations. This ability is further reduced by the BEP. However, both the
parametrization and the BEP favor a smooth transform which generally is a
reasonable assumption for medical images, particularly in low-contrast regions
where little anatomical information is available [114].
Especially in the case of MRI data, spatial intensity distortions may be present.
Hence, using the localized instead of the global form of MI is preferential in this
case as it evaluates the MI in subregions of the images only [109]. LMI is
advantageous also for multimodal registration if one intensity class corresponds
to a specific tissue type in one imaging modality and to different tissue types in
the other imaging modality [109]. Finally, if only a limited number of samples is
chosen during optimization to evaluate MI as performed in this study, choosing
the samples from a localized region may improve the statistical power of the
method.
For clinical application, a high registration accuracy in the tumor region is of
major importance. Since there was a temporal delay between the acquisitions
of the two PET images in our study, it is not expected that voxels of the same
anatomical position have the same intensity values, but the assessment of the
correlation of the PET images after registration still provides a meaningful mea-
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sure of correspondence. The high NCC between the PET images indicate that
surrounding anatomical structures in CT and MR give sufficient information for
the registration in the low contrast tumor region. In principle, the proposed
registration method could also be applied to other anatomical sites. However, a
re-optimization of the free parameters of the registration method may be favor-
able in this case to meet the different conditions of the specific body region.
PET/MR data can be integrated into biologically adapted RT in different
ways. Using contours derived from PET and MR [115] requires a high regis-
tration accuracy around the contour boundaries only. The situation is different
if data is to be integrated on a voxel basis as for Dose Paining By Numbers
(DPBN) [99]. In that case, intra-tumor registration accuracy is of highest im-
portance.
To date, it is not possible to acquire simultaneous PET/MR data in the HN
region with RT positioning aids. Therefore, it is beneficial that LMI+BEP yields
robust results also in the case of larger positioning differences between CT and
MR. Nevertheless, dedicated RT positioning aids compatible with PET/MR
would be favorable, since the final geometric accuracy achieved with DR will be
improved by a better initial alignment. By using appropriate positioning aids
strong local deformations could be avoided, which can not be correctly mapped
by the proposed algorithm due to its design. However, even with positioning
aids it is likely that slight deformations remain, and a DR in addition to a RR
may still be favorable. Particularly for the evaluation of treatment response, DR
allows to account for a shrinkage of the tumor. For final integration of PET/MR
data into RTP, the definition of PET as well as MR acquisition parameters
should be optimized to meet special RT requirements, such as a high, isotropic
resolution and correspondingly adjusted voxel sizes.
In conclusion, this study showed that DR with a B-spline parametrized trans-
form combined with LMI+BEP as optimization metric yields accurate and ro-
bust results for registration of CT and MR in the HN region. As a consequence,
this strategy for deformable multimodal image registration provides a basis for
the integration of individual molecular, functional and anatomical PET/MR
data into RTP.
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Patient characteristics
Table 4.2: Patient characteristics
Patient # Age Tumor localization TNM Volume [cm3]
Patient 1 57 Oropharynx cT3 cN2c M0 110.3
Patient 2 70 Hypopharynx cT4 cN2b cM0 52.4
Patient 3 62 Hypopharynx cT4 cN2c M0 89.0
Patient 4 64 Oropharynx cT4 cN2c M0 89.0
Patient 5 53 Oropharynx cT3 cN2c M0 104.0
Patient 6 44 Cervical lymph node rcN2b M0 361.1
Patient 7 57 Oropharynx cT2 cN2b M0 30.7
Patient 8 63 Mandibula cT2 cN0 cM0 23.2
Quantitative assessment of registration accuracy
Several measures for the determination of registration accuracy were imple-
mented using ITK and VTK (Visualization Toolkit, www.vtk.org). Measures
based on CT and MR as well as a measure derived from the PET images were
defined.
Several anatomical structures that were both visible on CT and MR were
segmented automatically if possible or manually otherwise, yielding volumes C
andM , respectively. These structures were skin, left and right carotid, and parts
of the respiratory tract. For all volumes C and M , polygonal surface meshes C
and M were extracted using the marching cubes algorithm [116]. Resulting C
were transformed to the coordinate system defined by the MR with the transform
obtained by registration, yielding C˜, from which the corresponding volume C˜ was
derived. For each pair of corresponding structures, the Dice Similarity Index
(DSI) was calculated as
DSI(C˜,M) = 2|C˜ ∩M ||C˜|+ |M | . (4.3)
Moreover, also mean distance measures were defined. For both skin and res-
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piratory tract, mean volume distances (MVD) were calculated as
MVD(C˜,M) = 12
 1
NC
NC∑
i=1
d(c˜i,M) + 1
NM
NM∑
i=1
d(mi, C˜)
 , (4.4)
where c˜i (mi) and NC (NM) are the spatial center of mesh element i and the
total number of mesh elements contained in C˜ (M), respectively, and d(pi,S) is
the shortest distance of point pi to the polygonal surface mesh S.
For the carotid volumes C and M , lines LC and LM defining the axial cen-
tre of the structures were extracted and LC was transformed according to the
registration result, yielding L˜C. For each slice i in the original MR containing
both a point c˜i from L˜C andmi from LM, the Euclidean distance d(c˜i,mi) was
calculated and the Mean Line Distance (MLD) was obtained as
MLD(L˜C, L˜M) = 1
NLP
NLP∑
i=1
d(c˜i,mi), (4.5)
where NLP is the total number of valid slices.
In addition, the bony structures were segmented from the CT as well as the
spinal canal from the MR image. For these two structures, the Non Overlapping
Fraction (NOF) was determined
NOF(C˜,M) = 1− |C˜ ∩M ||M | , (4.6)
where C˜ is the transformed volume of the bones segmented from the CT and M
is the volume of the spinal canal segmented from the MR.
Anatomical landmarks were defined on basis of the CT and the MR by two
experienced radiation oncologists, yielding landmarks {ci}NALi=1 and {mi}NALi=1 .
The mean number of available landmarks per patient was NAL = 7.5 (range: 4
– 10). For corresponding pairs of landmarks, the Mean Point Distance (MPD)
after registration was evaluated
MPD
(
{c˜i}NALi=1 , {mi}NALi=1
)
= 1
NAL
NAL∑
i=1
d(c˜i,mi). (4.7)
An additional measure was introduced to quantify the registration accuracy in
the tumor region. For this region, a validation of the local registration accuracy
is difficult based on the image information from CT and MR, since the intra-
tumor region can be of low contrast in these imaging modalities. However,
the additional PET images available in this study provide local information
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in this region. Therefore, the main tumor volume was derived from the PET
intensities in the PET/CT (IPC) using a threshold based segmentation method.
The resulting volume was expanded by a margin of 7mm, yielding the final
volume ΩT. In this volume, the Normalized Cross Correlation (NCC) of IPC
and the transformed PET of the PET/MR (I˜PM) is calculated:
NCC(IPC, I˜PM) =
∑
xi∈ΩT
(IPC(xi)− IPC)(I˜PM(xi)− I˜PM)√∑
xi∈ΩT(IPC(xi)− IPC)2
∑
xi∈ΩT(I˜PM(xi)− I˜PM)2
.
(4.8)
The NCC ranges from 0 to 1, where 0 means that the images are totally
uncorrelated, and 1 that there is a perfect positive linear correlation. In the
case of a high local registration accuracy of CT and MR, and thus also of the
PET images, the NCC is expected to have a value close to 1.
Exemplary dataset
Figure 4.5: Dataset of Patient 1. (A) PET/CT, (B) PET/MR.
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Registration parameters
Table 4.3: Parameters used in the multi-resolution approach of DR.
GMI GMI+BEP LMI+BEP
B-spline grid spacing (mm) 60/30/15 60/30/15 60/30/15
# iterations 5000 5000 5000
# samples 10000 10000 10000
# histogram bins 60 60 60
λ – 250 50
Lsub (mm) – – 40
The parameters below the dashed line were optimized with regard to the registration
quality measures defined above. If only one value is given, this value was used in all
resolution levels. For GMI+BEP and LMI+BEP different optimal values for λ were
determined. For GMI+BEP, λ = 250 yielded better quantitative results than λ = 50,
for which unrealistic deformations were observed for some of the patients.
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Abstract
Combined PET/MRI may be highly beneficial for radiotherapy treatment plan-
ning in terms of tumor delineation and characterization. To standardize tumor
volume delineation, an automatic algorithm for the co-segmentation of head
and neck (HN) tumors based on PET/MR data was developed. Ten HN patient
datasets acquired in a combined PET/MR system were available for this study.
The proposed algorithm uses both the anatomical T2-weighted MR and FDG-
PET data. For both imaging modalities tumor probability maps were derived,
assigning each voxel a probability of being cancerous based on its signal intensity.
A combination of these maps was subsequently segmented using a threshold level
set algorithm. To validate the method, tumor delineations from three radiation
oncologists were available. Inter-observer variabilities and variabilities between
the algorithm and each observer were quantified by means of the Dice similar-
ity index and a distance measure. Inter-observer variabilities and variabilities
between observers and algorithm were found to be comparable, suggesting that
the proposed algorithm is adequate for PET/MR co-segmentation. Moreover,
taking into account combined PET/MR data resulted in more consistent tumor
delineations compared to MR information only.
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5.1 Introduction
Modern radiation therapy (RT) treatment techniques like intensity modulated
RT (IMRT) allow for the application of sophisticated dose prescriptions [117].
However, to fully exploit the potential of these developments an accurate tumor
volume delineation is mandatory. Furthermore, with characterization of the
biological heterogeneity, non-uniform tumor dose prescriptions in terms of local
dose escalation are feasible [118,119].
For accurate tumor delineation and characterization the combination of in-
formation from different, complementary imaging modalities seems to be highly
beneficial. Anatomical magnetic resonance imaging (MRI) provides superior
soft tissue contrast compared to computed tomography (CT), and may thus
facilitate tumor delineation for RT treatment planning. Another advantage of
MRI compared to CT is the reduced extent of dental-inlay artifacts [28]. More-
over, functional MR imaging sequences like diffusion weighted MRI (DW-MRI)
and dynamic contrast enhanced MRI (DCE-MRI) may contribute to a biological
characterization of the tumor [98]. On the other hand, positron emission tomog-
raphy (PET) imaging with tracers like [18F]-fluorodeoxyglucose (FDG) or [18F]-
fluoromisonidazole (FMISO) may provide information about glucose metabolism
or hypoxia status of the tumor [99].
In general, PET and MRI provide complementary information due to the dif-
ferent underlying biophysical processes. Recently, combined PET/MR systems
have become available [47,48], allowing for the simultaneous acquisition of PET
and MR data. Combined PET/MRI provides intrinsically coregistered and com-
plementary anatomical and functional information of the tumor which may be
highly valuable for RT treatment planning [25,50].
With respect to advanced head and neck (HN) carcinomas, different studies
have shown that manual delineation of tumor volumes on anatomical MR images
yields smaller volumes with less inter-observer variation compared to CT [120,
121]. Other studies showed that anatomical MR data may provide more accurate
target volume delineation compared to CT [122,123]. On the other hand, in the
study of Daisne et al. [124] comparing information of CT, MRI and FDG-PET to
histology for oropharyngeal, laryngeal and hypopharyngeal cancer sites, tumor
delineations derived from FDG-PETmost accurately represented the histological
ground truth.
Manual delineation of tumor volumes often results in high inter-observer vari-
abilities [125]. For improved, standardized target volume definition automatic
segmentation algorithms may be beneficial. Concerning the automatic segmen-
tation of tumor volumes from FDG-PET images, different methods have been
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published previously [79,80]. However, literature addressing the segmentation of
anatomical MR images has mainly been focused on brain tumors [81,82], rather
than on tumors in the HN region [126]. Only few investigations have focused on
multi-modality co-segmentation, where most methods have been developed with
the aim of co-segmenting PET/CT data [127–129]. However, the random walk
based image co-segmentation algorithm of Bagci et al. was recently applied to
PET/MR data [130].
There are different challenges for the automatic segmentation of PET/MR
images. For HN cancer, the tumor is often surrounded by various tissues, which
may show various signal intensities in the MR image, and there may also be
pronounced intra-tumor variations. Moreover, standard MR images are not
quantitative, which complicates the assignment of signal intensities to underlying
tissue [131]. Additionally, there may not always be sharp edges between tumor
and normal tissue, but also diffuse transitions. Finally, MR images often have
anisotropic voxel sizes with a low resolution in one image dimension, especially
for diagnostic acquisitions. PET images are often characterized by a high level
of noise and low spatial resolution, which may impede tumor volume definition
especially in small uptake regions [132]. With respect to FDG-PET, there may
be physiological uptake and tumor subvolumes with low tracer uptake. Finally,
an appropriate way of deriving a tumor delineation respecting the information of
both modalities has to be identified, which is especially demanding when there
is conflicting information of PET and MR data.
In this work we present a co-segmentation algorithm for the automatic deriva-
tion of tumor delineations from combined PET/MR data comprising anatomical
T2-weighted MR and FDG-PET information. The goal is to improve standard-
ization and accuracy of target volume definition in the HN region by automat-
ing the delineation process and by integrating information from complementary
modalities. The method is validated by comparing the automatically derived
tumor delineations with manual contours of three experienced radiation oncol-
ogists.
5.2 Material and Methods
5.2.1 Patient data
Ten datasets from patients with HN cancer acquired in a combined PET/MR
scanner were available. Information about the patient characteristics is given
in Table 5.1. All patients gave their written informed consent to the PET/MR
examination and the use of their data for scientific purposes. The study was
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approved by the local institutional review board. PET/MR data were acquired
with the Siemens Biograph mMR (Siemens Healthcare, Erlangen, Germany). A
mean FDG activity of 354MBq (range: 320 – 388MBq) was injected. PET/MR
data were acquired after a mean time of 135min post injection (p.i.) (range:
120 – 166min p.i.). PET images were reconstructed using OSEM 3D with 3
iterations and 21 subsets and a 3D Gaussian filter of 3mm. MR-based PET
attenuation correction was performed by a segmentation approach based on
spoiled gradient-echo sequences with DIXON-based fat-water separation [61].
The MR datasets taken into account for this study were transversal T2-weighted
acquisitions using a short time inversion recovery (STIR) sequence (repetition
time/echo time/inversion time 4830/37/220 ms; flip angle 160 ◦). Voxel sizes of
the STIR and the PET images were 0.7×0.7×4.8mm3 and 2.8×2.8×2.0mm3,
respectively.
Table 5.1: Patient characteristics.
Patient Gender Age Tumor localization Histology TNM
1 m 70 Hypopharynx SCCa cT4 cN2b cM0
2 m 41 Sinonasal STCAb rcT4a cN0 cM0d
3 f 57 Oropharynx SCC cT3 cN2c M0
4 m 62 Larynx SCC cT4 cN2c M0
5 m 64 Oropharynx SCC cT4 cN2c M0
6 m 53 Oropharynx SCC cT3 cN2c M0
7 m 44 Cervical lymph node SCC cT0 rcN2b M0
8 f 57 Oropharynx SCC cT2 cN2b M0
9 f 77 Nasopharynx SCC rcT4 cN0 M0
10 f 63 Mandibula ESc cT2 cN0 cM0
asquamous cell carcinoma
bsinonasal teratocarcinosarcoma
cEwing sarcoma
din analogy to sinonasal carcinomas
5.2.2 Manual segmentations
For each patient, manual delineations of the gross tumor volume were provided
by three experienced radiation oncologists (FE, SW, CS), serving as a reference
for assessing the accuracy of the automatic segmentation algorithm. The radia-
tion oncologists were advised to delineate for each patient a volume considering
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MR data only, and a volume considering both MR and PET data simultaneously.
5.2.3 Co-segmentation algorithm
A schematic overview of the design of the proposed algorithm for automatic
PET/MR co-segmentation is shown in Figure 5.1. The PET image was resam-
pled to the MR image in a preprocessing step using B-spline interpolation of
third order. In addition, for each patient a region including the tumor was
roughly pre-defined. This was required to determine the maximal PET activity
concentration within the tumor (see below).
In a first step, tumor probability maps were derived for both the PET and
the MR image, assigning each voxel a probability of being cancerous based on
the respective signal intensity. For this purpose, a heuristic probability mapping
function (PMF) was defined specifically for each modality, relating intensity and
probability values on a voxel basis.
The PMF for the PET data (PMFpet) was assumed to be a logistic function
of the PET activity concentration a, providing the sigmoidal relationship
PMFpet(a) =
1
1 + s · exp(a− t1) . (5.1)
For setting parameters s and t1 the two conditions
PMFpet(amax) = 0.95 (5.2)
PMFpet(0.4 · amax) = 0.50 (5.3)
were enforced, with amax being the maximum activity concentration occurring in
the tumor containing region (Figure 5.1 b0). The condition given in Eq. 5.3 was
motivated by current threshold-based PET tumor segmentation methods [79,80].
The application of PMFpet to the PET image data yields the corresponding
tumor probability map (Figure 5.1 c0). From this map, a PET tumor volume
VpetGTV was automatically derived using a probability of 0.5 as threshold, which
is equivalent to performing a threshold segmentation on the original PET data
at 40 % SUVmax. Moreover, an isotropic margin of 10mm (VpetMarg) was defined
expanding VpetGTV followed by the subtraction of the original volume from the
expanded volume (Figure 5.1 d0).
The obtained volumes VpetGTV and VpetMarg were subsequently used to support
an adequate definition of the PMF for the MR data (PMFmr). For this purpose,
histograms of the MR signal intensities in both volumes were generated, and
corresponding probability density functions PDFmrGTV and PDFmrMarg were de-
rived by kernel density estimation (Figure 5.1 a1). The MR value of highest
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Figure 5.1: Schematic illustration of the proposed co-segmentation method. Based
on the PET/MR data (a0) a PMF is defined relating PET activity con-
centrations a to the probability of being caused by cancerous tissue (b0).
From the corresponding tumor probability map (c0), a PET tumor volume
VpetGTV and a margin VpetMarg are derived (d0). With the histograms of
MR signal intensities m in these volumes (a1) a PMF for the MR data is
defined (b1). A combined probability map (c2) is finally obtained by the
weighted sum of MR (c1) and PET probability maps (c0) according to
equation 5.8. Segmenting this map with a thLS algorithm yields the final
tumor volume (d2). The special case α = 0 is equivalent to segmenting
the MR probability map only (d1).
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probability according to PDFmrGTV was defined as m0, whereas the lower and
the higher intersection point of PDFmrGTV and PDFmrMarg were defined as m1
and m2, respectively. PMFmr (Figure 5.1 b1) was finally defined as a composite
of two logistic functions of MR signal intensity m
PMFmr(m) =

1
1+s1·exp(m−t1) , m ≤ m0
1− 11+s2·exp(m−t2) , m ≥ m0
(5.4)
Parameters s1, s2, t1 and t2 were set to meet the following conditions
PMFmr(m0) = 0.95 (5.5)
PMFmr(m1) = 0.50 (5.6)
PMFmr(m2) = 0.50. (5.7)
Thus, tumor probabilities of 0.50 were assigned to MR signal intensities occur-
ring with the same frequency in the PET-derived tumor volume and surrounding.
The corresponding tumor probability map was then derived by the application
of PMFmr to the MR image (Figure 5.1 c1).
Finally, a combined probability map was defined (Figure 5.1 c2) by a weighted
sum of the single maps. The probability p(m, a) assigned to a voxel of MR
signal intensity m and PET activity concentration a in the combined map was
set according to
p(m, a) = (1− α)PMFmr(m) + αPMFpet(a), 0 ≤ α ≤ 1. (5.8)
The parameter α determines the weight of the PET information relative to the
MR information and can be adapted to meet specific requirements.
The tumor delineation was subsequently derived with the threshold level set
(thLS) segmentation algorithm provided by the Insight Segmentation and Regis-
tration Toolkit (ITK)∗, version 4.5.2 (Figure 5.1 d2). In this method, the tumor
surface is represented by an isocontour of an implicit function which is itera-
tively evolved according to voxel-based information of a feature image and a
regularization term [133]. In this particular case, the combined tumor probabil-
ity map was used as feature image and the algorithm was initialized with the
signed distance map of the segmented PET volume VpetGTV.
For all segmentations, the curvature scaling parameter determining the amount
of regularization was set to 0.2, whereas the maximum number of iterations was
set to 1000. To derive an optimal value of α, segmentations were performed
on different probability maps, comprising α values ranging from 0 to 1 with a
step size of 0.1. Moreover, the threshold value of the thLS algorithm (thLS) was
optimized within the range from 0.30 to 0.55, with a step size of 0.05.
∗www.itk.org
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5.2.4 Evaluation of segmentation accuracy
Due to the limited number of patient datasets, no independent validation dataset
was available. To ensure that the optimized parameters are reasonable in terms
of not being overfitted, a leave-one-out cross-validation was performed. Param-
eters were optimized separately for each subset of nine patients and tested on
the remaining patient.
For evaluating the accuracy of the proposed co-segmentation algorithm, the
automatically obtained delineations were compared to those manually defined by
the three observers. In addition to the qualitative visualization of the manually
and automatically derived delineations, also a quantitative evaluation of both
inter-observer variability and variability between manually and automatically
defined segmentations was performed. Mutual scores of Dice similarity index
(DSI) as well as mutual distances between the surfaces of the tumor volumes
were evaluated. For distance quantification, a surface mesh was derived from
each volume by means of the marching cubes algorithm [116] using the Visual-
ization Toolkit (VTK)†. The comparison of two volumes V1 and V2 was subse-
quently performed by calculating the smallest distances of the centers of each
mesh element from the surface mesh of V1 to the surface mesh of V2. To treat
the volumes symmetrically, calculations were also performed vice versa. The
fraction of distances smaller than 3mm was used as measure of the agreement
between the tumor volumes. Thus, distances smaller than 3mm are regarded as
negligible, which is motivated by the typical size of the grid used for RT dose
calculation.
On the one hand, DSI and distance measures were evaluated for tumor de-
lineations derived from combined PET/MR information, where for the auto-
matically derived segmentations parameters α and thLS were optimized towards
optimal agreement with the manual delineations. On the other hand, manually
defined delineations from MR-only information were compared to segmentations
derived automatically with α = 0 and the thLS obtained by PET/MR-based op-
timization.
Tumor delineations derived from combined PET/MR information were tested
for statistically significant differences to MR-only derived delineations with a
two-sided paired Wilcoxon test. p-values lower than 0.05 were considered sta-
tistically significant.
†www.vtk.org
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Figure 5.2: DSI scores between tumor delineations defined manually using com-
bined PET/MR information and delineations derived automatically by
co-segmentation with different combinations of α and thLS. Each point
represents the median DSI value between the automatic segmentation and
the manually derived volumes averaged over all patients.
5.3 Results
In Figure 5.2, the tumor delineations yielded by the segmentation algorithm
are compared to those of the observers for different values of the parameters α
and thLS. Each point represents the median DSI value between the automatic
segmentation and the manually derived delineations averaged over all patients.
Using two significant digits, best agreement was obtained for the parameter com-
binations (α, thLS) = (0.5, 0.5) and (α, thLS) = (0.45, 0.6). Results of the leave-
one-out cross-validation are shown in Table 5.2. Since the determined optimal
parameters are very similar across the training datasets, the cross-validation in-
dicates that the parameter optimization is robust and may also perform well for
an independent validation dataset. (α, thLS) = (0.5, 0.5) was subsequently used
for a comprehensive comparison of the algorithm and the delineations defined
manually in the PET/MR images, whereas (α, thLS) = (0, 0.5) was evaluated
against MR-only derived delineations.
Figure 5.3 shows manually and automatically derived tumor contours for pa-
60
5.3 Results
Table 5.2: Results of the leave-one-out cross-validation.
Patient (α, thLS)a DSI training DSI validation
1 1, 2 0.76 0.86, 0.87
2 1, 2 0.76 0.87, 0.89
3 2 0.78 0.76
4 1, 2 0.77 0.78, 0.81
5 2, 3 0.77 0.82, 0.71
6 1, 2 0.79 0.54, 0.59
7 1, 2 0.79 0.60, 0.62
8 2 0.79 0.67
9 2 0.77 0.83
10 2 0.76 0.88
a(α, thLS) = (0.5, 0.5), 2: (α, thLS) = (0.45, 0.6), 3: (α, thLS) = (0.45, 0.5).
Note: For each patient, the optimal parameter combination (α, thLS) for the complementary
training dataset, consisting of the other nine patients, is shown together with the respective
patient-averaged DSI value (DSI training, two significant digits). Moreover, the DSI obtained
for the respective patient with the obtained parameter combination(s) is given (DSI valida-
tion). The DSI score taken into account is the median value between the automatic and the
manually derived delineations.
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(a) (b)
Figure 5.3: Exemplary tumor contours for patient 9. Contours of MR-based tu-
mor delineations from the three observers (green, black, blue) and co-
segmentation algorithm (red) with (α, thLS) = (0, 0.5) are shown (a),
as well as PET/MR-derived contours from the observers and the co-
segmentation algorithm with (α, thLS) = (0.5, 0.5) (b).
tient 9. For both MR-only and for PET/MR contours inter-observer variations
as well as variations between the observers and the algorithm were observed.
For a more detailed illustration of accordances and discrepancies of PET/MR-
derived delineations, Figure 5.4 shows several slices with contours of both the
observers and the automatic algorithm. From left to right variabilities between
the contours increase, with high discrepancies in the last slices.
The volumes of the manually and automatically derived tumor segmentations
using MR-only as well as combined PET/MR information are visualized in Fig-
ure 5.5. High differences in the volumes occurred among the observers when
tumor boundaries could not be clearly identified on the image data (cf. patient
7). Other cases showed only minor variations for both MR-only and combined
PET/MR derived tumor volumes (cf. patient 10). In general, additional PET
information can both lead to an increase and a reduction of the defined tumor
volume. However, volumes tended to decrease as shown by the volumes averaged
over all patients.
Quantitative results of the variability between tumor delineations in terms of
DSI and distance evaluations are shown in Figure 5.6 for both MR-based delin-
eations and PET/MR-based delineations. A DSI value of 0.67 ± 0.17 (mean ±
stddev) was obtained for MR-based delineations when combining the result of
the three pairs of observers, whereas 0.69±0.14 was obtained for the comparison
of manually and automatically defined delineations. For combined PET/MR in-
formation values were 0.72± 0.13 and 0.75± 0.12, respectively. For the fraction
of distances smaller than 3mm, MR-only derived delineations yielded 0.78±0.17
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Figure 5.4: Tumor contours obtained for patient 4. PET/MR-derived contours from
the observers (green, black, blue) and the co-segmentation algorithm (red)
with (α, thLS) = (0.5, 0.5) are shown overlayed on the MR (first row)
and PET images (second row), with n indicating the corresponding slice
number.
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Figure 5.5: Volumes of tumor delineations derived by the observers (M1/M2/M3) and
the co-segmentation algorithm (A) for each patient. ’av’ denotes the
volume averaged over all ten patients. Both MR-derived volumes with
(α, thLS) = (0, 0.5) for automatic segmentation (a) and PET/MR-derived
volumes with (α, thLS) = (0.5, 0.5) (b) are shown.
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Figure 5.6: Comparison of tumor volumes from the three different observers
(M1/M2/M3) and the automatic method (A). Boxplots show mutual DSI
values (a,b) and fractions of inter-surface distances within 3mm (c,d) ob-
tained for the patient cohort (N = 10). Both MR-only volumes with
(α, thLS) = (0, 0.5) for automatic segmentation and PET/MR-derived
volumes with (α, thLS) = (0.5, 0.5) are shown.
for inter-observer comparison and 0.82± 0.14 for comparison between automat-
ically and manually derived delineations. For combined PET/MR information
values changed to 0.81 ± 0.16 and 0.88 ± 0.10, respectively. Both the evalua-
tion of DSI and distances show that substantial differences in tumor delineation
were obtained for both MR-only and PET/MR derived volumes. However, both
the concordance between manual volumes and between manually and automat-
ically derived delineations increased significantly when complementing MR in-
formation by PET information according to DSI as well as distance evaluation
(p < 0.05). Most importantly, variabilities between automatic and manual con-
tours are comparable to the inter-observer variabilities for both MR-only and
PET/MR derived delineations.
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In this work, an algorithm for co-segmenting tumor volumes based on PET/MR
information was presented and evaluated against manual delineations of three
observers. Since there are free parameters, the proposed method has potential
for calibration. We optimized the parameter defining the relative weight of the
probability maps, α, and the threshold used in the thLS algorithm, thLS, with re-
spect to maximum agreement of the automatically defined volumes with those of
the three observers. This yielded the parameter combinations (α, thLS) = (0.5,
0.5) and (α, thLS) = (0.6, 0.45), respectively, using two significant digits for
comparing DSI scores. With α = 0.5 the PET and MR data contribute equally
to the segmentation. Since α was optimized with respect to best agreement
with the three observers, this indicates that the observers tended to incorporate
MR- and PET-based information to a similar extend for deriving contours from
PET/MR data. However, also other values for α would have been plausible, be-
cause an increased overall reliance on one or the other modality could in general
be reasonable. thLS = 0.5 means that the segmentation border is determined by
voxels having equal probabilities of being cancerous or not cancerous. An opti-
mal value of about 0.5 thus suggests that the PMFs are defined in a reasonable
way.
The leave-one-out cross-validation indicates robust parameter optimization
without overfitting to the available patient cohort. Moreover, MR-based seg-
mentation (α = 0) yields results which are within inter-observer variability us-
ing only one optimized parameter (thLS). However, an independent validation
of the algorithm should be performed when more patient datasets are available.
Also the performance of the algorithm on other tumor sites could be evaluated
in a further work.
Tumor volumes obtained by the co-segmentation algorithm tended to be smaller
than volumes defined by the observers (cf. Figure 5.5), especially for delineations
derived from combined PET/MR information. In general, larger volumes could
be obtained with a thLS value lower than 0.5. However, thLS was optimized
with respect to DSI, which not only compares sizes of derived tumor volumes,
but also the spatial concordance. For further assessment of this tendency, the
evaluation on more patient datasets would be preferable.
Comparison of mutual DSI scores and mutual distances of tumor volumes
showed that variabilities between different observers are similar to variabilities
between manually and automatically derived volumes. This suggests that the
automatic co-segmentation algorithm yields results with an accuracy compa-
rable to clinical practice. Compared to MR-only information, using combined
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PET/MR information resulted in a statistically significant improvement of the
agreement between observers, as well as between observers and the automatic
algorithm, supporting the assumption that the usage of multi-modality data in-
creases the consistency of tumor definition [134]. However, both inter-observer
variabilities and variabilities between observers and the automatic segmenta-
tion method are still considerable. These variabilities are likely to be reduced
when more complementary imaging information is available, e.g. from addi-
tional MR sequences. Since the proposed co-segmentation method is modular,
additional imaging data could easily be integrated by defining appropriate prob-
ability maps. As an example, quantitative functional data derived from DW-
or DCE-MRI could help to obtain more accurate delineations. Compared to
anatomical MR data, the definition of PMFs based on quantitative image data
is simplified, since their voxel values have a well-defined meaning.
Segmentation of anatomical MR images is especially challenging since there is
no standard intensity scale in MRI, which impedes a straightforward assignment
of signal intensities to underlying tissue [131]. Moreover, high signal intensities
in T2-weighted images may be caused by increased water content due to in-
flammation or edema [135]. Thus, contrarily to PET, a PMF monotonically
increasing with signal intensity may not be adequate for MR images. However,
the results obtained by the proposed algorithm for MR-only segmentation show
that information from PET data can guide the derivation of an appropriate
PMF for MR data. Though providing complementary information, FDG-PET
seems to be sufficiently correlated with the MR information for this purpose.
The method proposed in this study to include MR information in a margin
VpetMarg encompassing the PET-derived tumor segmentation (cf. Figure 5.1 d0)
was found to be crucial for defining an adequate PMF for the MR data. Thus,
information about the contrast between tumor and surrounding tissue seems to
be mandatory for this purpose.
An additional issue concerning MR images is the high level of anisotropy with
a low resolution in one direction, which is often present especially in diagnostic
images. The MR images available in this study had an out-of-plane voxel spacing
of 4.8mm. Since this limits segmentation accuracy, high resolution isotropic
acquisitions would be preferable [136].
Concerning the PET images, the relative threshold segmentation and conse-
quently also the tumor probability maps may be influenced by the method used
for PET image reconstruction [137]. When using different image reconstruc-
tion methods, the influence on the algorithm should be evaluated and thresh-
olds should be adapted, if necessary. Moreover, PET images from combined
PET/MRI are influenced by MR-based attenuation correction. This constitutes
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a potential source of uncertainty for PET quantification. In particular, the PET
data is not completely independent of MR-based information [138].
In the proposed method, the thLS algorithm is used for segmenting the tumor
probability maps. In contrast to a simple threshold segmentation, thLS is not
only based on bare voxel intensities but also includes a regularization of the seg-
mented surface. Moreover, the risk of “leakage” of the segmentation is reduced
compared to the conventional level set algorithm [139], for which difficulties oc-
cur at weak tumor boundaries since it depends on edge information. Level set
algorithms allow for topological changes during optimization, which renders the
algorithm adaptive to diverse tumor geometries such as a tumor enclosing the
trachea. Moreover, the regularization is performed in three dimensions, therefore
the segmentations between adjacent slices are interdependent.
In general, standardization of tumor volume delineation is highly beneficial.
This supports the usage of automatic tumor segmentation algorithms. How-
ever, a visual inspection is still mandatory and may imply manual corrections.
Nonetheless, if a common starting segmentation is provided, inter-observer vari-
ations are supposed to decrease.
For a further validation of the algorithm, a comparison to histology would be
preferable [124], as histology most closely reveals the ground truth. Moreover,
histological details would also provide more evidence for the definition of PMFs.
Such an evidence-based PMF definition could be guided by the sensitivities and
specificities of the respective imaging modalities.
To finally integrate results into RT treatment planning, the tumor segmen-
tation derived from PET/MR has to be transferred to the CT acquired for
treatment planning. In general, an accurate deformable registration strategy is
necessary for spatially matching the PET/MR data to the planning CT [140].
However, these algorithms are hard to validate and spatial inaccuracies remain.
Since registration accuracy increases with identical patient positioning, a solu-
tion allowing for RT specific positioning of HN patients in the PET/MR sys-
tem [141] would be highly preferable. Another perspective is PET/MR-only
treatment planning. For this approach, CT equivalent information has to be
derived from MRI for RT dose planning as well as for PET attenuation correc-
tion [67]. In combination with an accurate PET/MR-based tumor segmentation
strategy and methods for adapting the dose prescription within the tumor ac-
cording to functional datasets and associated locoregional control probabilities,
a biologically individualized PET/MR-only based treatment planning could be
possible in the future.
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5.5 Conclusion
The proposed PET/MR co-segmentation algorithm yielded tumor volumes which
were comparable to manually defined volumes when taking into account mutual
variabilities. Following further evaluation of the algorithm it may be used as
a tool to define a standardized starting point for RT tumor volume definition,
which consequently may reduce inter-observer variations. Additional imaging
information can readily be incorporated in the method. Therefore, it provides a
basis for integrating multimodal imaging information into RT planning.
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Abstract
Purpose The aim of this pilot study was to explore simultaneous functional
PET/MR for biological characterization of tumors and potential future treat-
ment adaptations. To investigate the extent of complementarity between dif-
ferent PET/MR-based functional datasets, a pairwise correlation analysis was
performed.
Methods Functional datasets of N=15 head and neck (HN) cancer patients were
evaluated. For patients of group A (N=7), combined PET/MR datasets includ-
ing FDG-PET and ADC maps were available. Patients of group B (N=8) had
FMISO-PET, DCE-MRI and ADC maps from combined PET/MRI, an addi-
tional dynamic FMISO-PET/CT acquired directly after FMISO tracer injection
as well as an FDG-PET/CT acquired a few days earlier. From DCE-MR, param-
eter maps Ktrans, ve and vp were obtained with the extended Tofts model. More-
over, parameter maps of mean DCE enhancement, ∆SDCE, and mean FMISO
signal 0-4 min p.i., AFMISO, were derived. Pairwise correlations were quantified
using the Spearman correlation coefficient (r) on both a voxel and a regional
level within the gross tumor volume.
Results Between some pairs of functional imaging modalities moderate correla-
tions were observed with respect to the median over all patient datasets, whereas
distinct correlations were only present on an individual basis. Highest inter-
modality median correlations on the voxel level were obtained for FDG/FMISO
(r = 0.56), FDG/AFMISO (r = 0.55), AFMISO/∆SDCE (r = 0.46), and FDG/ADC
(r = −0.39). Correlations on the regional level showed comparable results.
Conclusion The results of this study suggest that the examined functional datasets
provide complementary information. However, only pairwise correlations were
examined, and correlations could still exist between combinations of three or
more datasets. These results might contribute to the future design of individu-
ally adapted treatment approaches based on multiparametric functional imaging.
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6.1 Introduction
Biological tumor characterization based on functional and molecular imaging
might be highly valuable for radiotherapy (RT). On the one hand, it could allow
for an improved target volume definition and an individualized dose prescription
within the tumor according to local biological characteristics. Such dose paint-
ing strategies can be readily applied with the technical availability of intensity
modulated RT (IMRT). Moreover, functional imaging might be of high value
for early response assessment and potential treatment adaptation in the course
of fractionated RT [52, 53]. Other fields of application are the assessment of
chemotherapy and the application of targeted agents, such as hypoxia-sensitizing
or antiangiogenic drugs [86,87].
Both positron emission tomography (PET) and magnetic resonance imaging
(MRI) may provide functional information beneficial for personalized treatment
strategies. PET imaging using [18F]-fluorodeoxyglucose (FDG) can be used to
monitor glucose metabolism, whereas the hypoxic status of the tumor can be
assessed using dedicated tracers such as [18F]-fluoromisonidazole (FMISO). Dif-
fusion weighted MRI (DW-MRI) provides the possibility to quantify the dif-
fusion of water molecules, which is related to cellular density [29]. Dynamic
contrast-enhanced MRI (DCE-MRI) yields a temporally varying signal due to
the distribution of contrast agent in blood pool and tissue. By compartmental
modeling estimates of quantitative physiological parameters can be derived [92].
With the advent of combined PET/MR imaging [47, 48] the acquisition of
simultaneous, intrinsically registered PET and MR data has become possible.
This facilitates the comparison and combined analysis of PET- and MR-derived
functional imaging data. Simultaneous PET/MR may thus be of high potential
for treatment individualization [25,50].
Recent studies have associated different functional imaging information with
RT outcome for head and neck (HN) cancer. This applies to FDG-PET [17,
41], static as well as dynamic FMISO-PET [18, 19, 43, 44], apparent diffusion
coefficients (ADCs) inferred by DW-MRI [14], as well as DCE-MRI [15, 16].
These studies provide a rationale to adapt RT treatment plans according to
functional imaging information.
It is not clear yet if datasets from different functional imaging modalities are
completely complementary, or if information is to some extent redundant. Initial
analyses of correlations between different functional datasets have already been
performed in recent studies. The studies of Rajendran et al. [142] and Thorwarth
et al. [143] revealed good voxel-by-voxel correlation of FDG and FMISO in some
HN tumors, whereas others showed no clear correlation. The biological basis of
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the observed correlations may be the hypoxia-inducible factor 1α (HIF 1α) [142].
Similar results were obtained by Zegers et al. [144] comparing uptake of FDG and
the hypoxia PET tracer [18F]-HX4 in patients with non–small cell lung cancer.
Houweling et al. [145] quantified correlations between FDG and ADC maps of
HN tumors on a voxel level, and found a negative correlation in most patients.
Both Newbold et al. [146] and Donaldson et al. [147] found correlations between
hypoxia derived from pimonidazole staining and DCE-derived parameter maps
on a region-of-interest (ROI) level. A study by Jansen et al. [148] found that neck
nodal metastases with positive FMISO uptake differed significantly in median
Ktrans values from those with no FMISO uptake.
Earlier studies have shown that a dynamic imaging protocol may be superior
compared to a single time frame for hypoxia quantification using FMISO-PET
[44]. However, in addition to a late static scan several hours post injection
(p.i.), such a dynamic protocol requires a PET acquisition during tracer wash-in
in the first minutes p.i. [149], which may hamper its usage in clinical routine.
A positive correlation result between early FMISO and DCE information would
potentially provide the possibility to infer early FMISO information from DCE,
which would facilitate its clinical usage.
To address the question if available functional information of PET/MR is
complementary or to some extend redundant, this study extends beyond exist-
ing studies by considering a comprehensive set of functional data. Correlations
of various functional datasets are quantified on a voxel as well as on a regional
level within HN tumors by means of the Spearman correlation coefficient. For
the analysis, FDG-PET, FMISO-PET acquired in the wash-in, as well as in
the retention phase, ADC maps extracted from DW-MRI, and DCE-MRI de-
rived maps are taken into account. The study is a first explorative, hypothesis
generating approach to investigate the utilization of integrated PET/MR for
personalized treatment strategies.
6.2 Material and Methods
6.2.1 Patient data
Datasets from 15 HN cancer patients from two different studies were available in
total, examined with combined PET/MR (Biograph mMR, Siemens Healthcare,
Erlangen, Germany) and PET/CT (Biograph mCT, Siemens Healthcare, Erlan-
gen, Germany) before the start of RT. The studies were approved by the local
ethics committee. All patients gave written informed consent for participating
in the imaging studies.
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For 7 patients (group A) the PET/MR imaging session was performed about
2 h (120 – 166min, median: 129min) after injection of FDG (320 – 388MBq, me-
dian: 357MBq). The other 8 patients (group B) were imaged 0–40min after
injection of FMISO (165 – 377MBq, median: 339MBq) in PET/CT using a dy-
namic acquisition mode, with a subsequent PET/MR imaging session about
3 h p.i. (164 – 206min, median: 174min). For these patients, an additional
FDG-PET/CT (307 – 354MBq, median: 330MBq) acquired 1 – 30 days earlier
(median: 8 days) at about 1 h p.i. (55 – 81min, median: 71min) was also avail-
able. An overview of the patient cohort including the imaging data available for
each patient is shown in Table 6.1.
PET images obtained from PET/MR were reconstructed to a voxel size of
2.8 × 2.8 × 2.0mm3 using an OSEM 3D algorithm with 2 iterations and 21
subsets (2i21s) and a 3D Gaussian filter of 4mm. MR-based PET attenuation
correction was performed by a vendor-provided segmentation approach based on
spoiled gradient-echo sequences with DIXON-based fat-water separation [61].
FMISO-PET images from the PET/CT were reconstructed to a voxel size of
4.1 × 4.1 × 5.0mm3 using OSEM 3D with 4i8s and a 3D Gaussian filter of
5mm. FDG-PET images from the PET/CT were reconstructed to a voxel size
of 2.0 × 2.0 × 3.0mm3 using OSEM 3D with 3i24s and a 3D Gaussian filter of
3mm.
MRI acquisitions at the Biograph mMR were performed with the standard 16
channel head neck coil. An anatomical, transversal T2-weighted acquisition us-
ing a short time inversion recovery (STIR) sequence was acquired for each patient
(repetition time (TR)/echo time (TE)/inversion time (TI) = 4830ms/37ms/220ms,
flip angle 160°, voxel size 0.7× 0.7× 4.8mm3, bandwidth 220Hz/px, 2 averages,
acquisition time 3m58s).
In addition, DW-MR images were obtained using a single-shot spin-echo echo-
planar imaging (TR/TE = 7400ms/49ms, b-values 50 s/mm2 and 800 s/mm2,
bandwidth 2083Hz/px, voxel size 2.1×2.1×5.0mm3, 3 averages, spectral atten-
uated inversion recovery fat suppression, acquisition time 2m26s). ADC maps
were obtained from the scanner software (Syngo MR B18P).
ForN=5 patients also DCE-MR datasets were obtained. An axial T1-weighted
fast spoiled gradient echo sequence (TWIST, TR/TE = 2.86ms/1.01ms, flip
angle 12°, voxel size 1.1 × 1.1 × 4.0mm3, temporal resolution 2.9 s, bandwidth
530Hz/px, acquisition time 4m18s) was performed after an automatic fast bolus
injection of 0.1mmol Gd-DTPA per kg patient weight, followed by a saline flush.
The field of view included the entire tumor and the common carotid arteries.
For the derivation of the native longitudinal relaxation times needed for DCE-
quantification, additional VIBE sequences were acquired with two different flip
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6.2 Material and Methods
angles (α1 = 2 °, α2 = 12 °) before contrast agent injection (TR/TE = 4.04ms/1.52ms).
The image grid was identical to the one of the DCE-MR acquisitions.
6.2.2 Calculation of parameter maps
The activity of the dynamic FMISO-PET datasets acquired during tracer wash-
in was integrated for each voxel between 0 to 4min p.i. using the rectangle
method. By normalizing with respect to the acquisition time range of 4min,
a map of mean activity, AFMISO, was obtained. For DCE images, the time-
dependent signal enhancement of each voxel was calculated by subtraction of
the mean signal before contrast agent injection. Subsequently, maps of mean
signal enhancement ∆SDCE from 0 to 4min p.i. were calculated analogous to
the AFMISO maps.
Before compartmental analysis, DCE images were resampled to the FMISO
image grid from PET/MR. Signal-time-curves of DCE were fitted with an in-
house implemented software (Matlab R2014b) using the extended Tofts model
[90] and the Levenberg-Marquardt least squares algorithm. The arterial input
function (AIF) was derived for each patient independently from a fit of the
signal-time curve in the common carotid artery. Parameter maps of the volume
fraction of the extracellular-extravascular space (EES), ve, the volume fraction
of the blood plasma, vp, and the volume transfer rate from plasma to the EES,
Ktrans, were obtained. For regional analysis (see below) compartmental analysis
was performed separately on the regional level of 3×3×4 voxels of the resampled
DCE images.
6.2.3 Image registration and tumor volume delineation
For performing the correlation analysis, the GTV of each patient from group
A was delineated by an experienced radiation oncologist based on combined
information of the FDG-PET and the T2-weighted STIR image [150]. ADC
maps were resampled to match the FDG image grid with b-spline interpolation of
3rd order using the Insight Segmentation and Registration Toolkit (ITK version
4.5.2, www.itk.org).
For delineation of the GTVs of group B, manual contours defined by an expe-
rienced radiation oncologist on corresponding planning CTs were transferred to
the PET/MR datasets by deformable registration of the CT and STIR images.
The registrations were performed with elastix [110] using a b-spline parametrized
transform and mutual information as similarity measure. Details of the used
deformable registration algorithm and the respective parameter set are given
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in [140]. ADC images from PET/MR were resampled to match the FMISO
image grid. Additionally, the FDG image from PET/CT was transformed to
the FMISO image grid from PET/MR by deformable registration of the corre-
sponding CT and STIR images with the method described above. The AFMISO
map was registered to the PET/MR dataset in the same way.
6.2.4 Statistical analysis
Correlation analysis was performed for all available pairwise combinations of
functional and parametric maps with Python 2.7.6 using the SciPy library
(www.scipy.org). Correlations were quantified by evaluating for each patient
seperately the Spearman correlation coefficient on a voxel as well as on a re-
gional level within the GTV. For voxel-based analysis, samples were defined by
the PET image grid from PET/MR. For regional analysis, samples were defined
as averages from non-overlapping sub-regions of the GTV. Each sub-region was
defined over 3× 3× 4 voxels of the PET image grid, corresponding to a size of
8.4 × 8.4 × 8mm3. Patients with less than ten subregions were excluded from
regional analysis (cf. Table 6.1).
6.3 Results
All functional images and parameter maps used for pairwise correlation analysis,
together with the anatomical STIR acquisition and the delineated GTV, are
exemplarily visualized for Patient 11 in Figure 6.1.
Exemplary scatter plots of the voxel-based pairwise correlation analysis are
shown in Figure 6.2, visualizing results of two exemplary patients. Scatter
plots and corresponding correlation coefficients show that there were patients
for which pairs of functional data which showed rather strong correlations (e.g.
FDG/ADC, ∆SDCE/AFMISO for Patient 11), while for other patients the corre-
lations of the same pairs were much lower (cf. Patient 14).
Figure 6.3 shows a correlation matrix representing the median Spearman cor-
relation coefficients obtained over the available patient datasets for all pair-
wise combinations of functional data, both for voxel-based and regional anal-
ysis. Highest inter-modality median coefficients of the voxel-based analysis
were obtained for the combinations FDG/FMISO (r = 0.56, range: 0.08 – 0.80,
N = 8), FDG/AFMISO (r = 0.55, range: 0.19 – 0.76, N = 8), AFMISO/∆SDCE
(r = 0.46, range: 0.30 – 0.57, N = 5), and ADC/FDG (r = −0.39, range: -
0.82 – 0.30, N = 13). For regional analysis, values changed to FDG/FMISO
(r = 0.51, range: 0.06 – 0.86, N = 7), FDG/AFMISO (r = 0.32, range: -0.02 –
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Figure 6.1: Dataset of Patient 11, showing transversal slices of the anatomical T2-
weighted image (STIR), ADC map, FMISO image at 3 h p.i., the DCE-
derived maps Ktrans, ve and vp, the maps of mean signal enhancement
∆SDCE and mean FMISO activity AFMISO in the time range of 0–4min
p.i, and the FDG image at 1 h p.i. All images and parameter maps were
acquired in a single PET/MRI session, except for the FDG image and
the AFMISO map which were transferred to the PET/MR dataset by de-
formable registration. The delineation of the GTV is shown in red.
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Figure 6.2: Exemplary scatter plots for Patients 11 (top) and 14 (bottom), with sam-
ples obtained on the voxel level. For increased comparability across pa-
tients, FDG activity concentrations were converted to standardized uptake
values (SUVs). FMISO data was normalized by devision by the back-
ground signal in a deep neck muscle, resulting in the tumor to background
ratio (TBR). The Spearman correlation coefficients r associated with the
scatterplots are shown within each plot.
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Figure 6.3: Correlation matrix showing for each pair of functional information the me-
dian Spearman correlation coefficients obtained over all respective patient
datasets. The upper right triangle shows coefficients derived on the voxel
level, whereas the lower left triangle shows the coefficients derived on the
regional level.
0.61, N = 7), AFMISO/∆SDCE (r = 0.40, range: -0.09 – 0.61, N = 5), and
ADC/FDG (r = −0.28, range: -0.98 – 0.62, N = 10).
The inter-patient variation of Spearman correlation coefficients for both voxel
and regional analysis are shown in Figure 6.4 for the pairs of highest median
voxel correlations. Moreover, correlation coefficients are shown for each patient
individually in Figure 6.5.
6.4 Discussion
While weak correlations were observed between some functional imaging modal-
ities in the median over all patient datasets, distinct correlations were only
present on an individual basis. This applies both to the voxel-based and the
regional analysis. FDG and FMISO showed the largest inter-modality median
correlations in our study. However, the respective correlation coefficients varied
strongly within the patient cohort. This result is in line with the findings of Ra-
jendran et al. [142] and Thorwarth et al. [143]. Similar to Houweling et al. [145],
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Figure 6.4: Boxplots showing the inter-patient variation of Spearman correlation coef-
ficients for the pairs with the highest median voxel correlations according
to Figure 6.3. For each functional pair, the results from voxel-based anal-
ysis (dark color, left boxes) and from regional analysis (light color, right
boxes) are shown.
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moderate negative correlations were observed between FDG and ADC, with a
pronounced variability across patients. No correlations were observed between
FMISO and DCE-derived parameters maps. This is different from Newbold et
al. [146], Donaldson et al. [147], and Jansen et al. [148]. However, our study is
not readily comparable to the results of these authors, since the first authors
quantified hypoxia by means of pimonidazole staining after tumor resection and
the latter performed the analysis for neck nodal metastases.
We also found a moderate correlation between AFMISO and ∆SDCE. This indi-
cates that they may be measures of similar physiological parameters. However,
according to this first analysis the observed correlation does not seem to be
sufficient to infer the early FMISO information during wash-in from the DCE
data. Instead of using ∆SDCE maps directly for correlation analysis, they could
have also been converted to maps of contrast agent concentration using native T1
maps derived from the VIBE acquisitions. While this might have a slight impact
on correlations quantified with the Spearman coefficient due to the dependency
of the relation between signal enhancement and concentration on native T1, the
conversion to concentration maps would introduce an additional source of error
due to uncertainties in native T1 derivation.
For ADC and ve maps, correlations may be expected as ADC is commonly
related to the fraction of EES, and ve is interpreted as the fraction of EES itself.
However, in our study weak correlations are only observed on a regional level.
One explanation of missing correlations could be that DCE parameter maps
in regions with low vascularization are not reliable due to the weak delivery of
contrast agent. However, correlation analysis between ADC and ve should be
performed with further datasets to provide more representative results.
Some of the highest correlations were found between the DCE-based maps
Ktrans, ve, vp, as well as ∆SDCE. This may be either due to inherently correlated
parameter estimates in the extended Tofts model used for data analysis, or due
to biological relations between the respective parameters.
The determination of multimodal parameter correlations may be substantially
compromised by different factors, such as geometrical inaccuracies associated
with imaging techniques and image registration, as well as interpolation errors
and statistical uncertainties. Geometrical distortions are particularly present
in the ADC maps, which were acquired using EPI sequences. For future ac-
quisitions, ideally sequences which are less prone to geometrical distortions
should be used in combination with a method for geometrical distortion cor-
rection [151, 152]. Also, since no patient positioning system was used during
image acquisition in the combined PET/MR examinations, movement of the
patients during image acquisition cannot be excluded a priori. Hardware so-
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lutions for effective patient immobilization are currently being developed [141].
Finally, geometrical uncertainties are associated with images that were trans-
ferred to the PET/MR datasets by deformable registration, which may lead to
a reduction of absolute correlation values [153]. An independent analysis of the
errors introduced by the different factors is not possible with realistic patient
data. In order to account for geometrical uncertainties, a correlation analysis
on a regional level was added to the voxel analysis. Such a regional analysis
is more robust with respect to geometrical uncertainties, interpolation errors
and image noise, whereas averaging may underestimate existing correlations,
and additional statistical uncertainties may be introduced. Both increases and
decreases in correlation coefficients compared to the voxel-based analysis were
observed. However, similar inter-patient distributions were observed (cf. Fig-
ure 6.4). As a main result of our study we found large variations of correlation
coefficients between patients, which most probably can not be explained by the
present inaccuracies alone.
DCE parameter maps were derived with the extended Tofts model. However,
model parameters may be misinterpreted for some physiological conditions such
as highly vascularized tissues with intermediate flow [154]. For other conditions,
the model may not fit the data accurately. Other models with fewer assumptions
like the four parameter two-compartment exchange model (2CXM) could be used
instead if data quality is sufficient in terms of temporal resolution, signal-to-noise
ratio and artifacts [92].
Only a limited number of patients was available in this study, especially with
respect to DCE-MRI data. Further evaluation should be performed when more
patient data is available.
The results in this study extend the correlation analyses performed in previ-
ous studies by considering a comprehensive set of functional data. The present
results suggest that the different functional datasets derived from DCE-MRI,
DW-MRI, FDG-PET and FMISO-PET provide complementary information.
Since all these imaging methods were proven to be prognostic for treatment
outcome [14–19, 41, 43, 44], this suggests that each method may be of separate
value for the adaptation of treatment strategies. However, only pairwise cor-
relations have been analyzed so far. It appears interesting to elaborate if the
information from one functional imaging method could be deduced from a com-
bination of several other functional imaging methods. Such an analysis could
in the future be performed with machine learning approaches [155] when more
patient datasets are available. On the other hand, one may obtain more coher-
ent correlation results if only subgroups of HN tumors are analyzed, for example
patients with equal tumor localization, size and staging.
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Analyses exploring a potential redundancy between functional PET/MR data
may be of value for RT and other treatment modalities due to several rea-
sons. Firstly, using redundant image data and parameter maps for biologically
adapted treatments would unnecessarily increase the number of parameters to
be adapted with respect to improved outcome. Thus, the correlation analysis
performed in the present study constitutes a first step towards the integration of
functional imaging into treatment individualization. Before biologically adapted
treatments can be used clinically, a number of additional steps are required, such
as the correlation of functional parameters to treatment outcome and a thorough
regional failure analysis. Further research is needed to clarify which parameter
combination provides accurate information about locoregional control probabil-
ity. Secondly, functional imaging data may concatenate multiple physiological
parameters, and interpretation is not always straightforward. A more detailed
understanding of functional images and the parameter maps obtained by post-
processing models is necessary [154,156]. Exploring a potential inter-dependency
between different datasets may support the interpretation of functional imag-
ing data. Moreover, present or missing correlations between different datasets
could potentially also be associated with biological evidence related to treat-
ment response of individual patients. A more comprehensive picture of these
issues would allow for a knowledge-driven treatment adaptation, which would
then need to be validated in clinical trials.
6.5 Conclusion
Multiparameteric PET/MR provides a substantial amount of different functional
imaging data, which may be highly beneficial for cancer treatment adaptation.
The results of our study suggest that the associated datasets provide complemen-
tary information, and thus could all be of separate value for defining treatment
adaption strategies, as well as for treatment response assessment and follow-up.
Results of this correlation study might in the future contribute to the design of
individually adapted treatment approaches based on multiparametric functional
PET/MR imaging.
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Concluding discussion
Radiation treatment with IMRT as well as advanced imaging methods have
become available in the last years, potentially providing a basis for major ad-
vancements in RT treatment. In this respect, combined PET/MR provides a
plethora of co-registered multimodal imaging information for tumor delineation
and characterization. In this thesis, several image processing algorithms and
methods for integrating PET/MR data into RT have been developed and eval-
uated. All studies were performed on a limited number of patient datasets, and
can thus be considered primarily as a methodological development, for which
further evaluation and potential adjustment of parameters and methods should
be pursued in future. In the following, conclusions from the performed studies
are summarized and limitations as well as potentials are discussed.
The accuracy of the algorithm developed for deformably registering MR and
CT datasets (Part I ) was found to be in the order of half the voxel size of the
images. It may therefore be of sufficient accuracy for the integration of PET/MR
data into the RT planning process. However, for clinical application, a further
evaluation on more patient datasets is necessary.
Deformable registration algorithms and their validation are in general asso-
ciated with difficulties. Deformable registration is an ill-posed problem [114].
In homogeneous regions with low structural information, there is little evidence
about the ’true’ spatial correspondence. Tumors often appear homogeneous
in anatomical images, while functional imaging methods may reveal a biological
heterogeneity. Thus, if functional imaging information should be co-transformed
to the reference image for local tumor characterization, the registration accu-
racy in the tumor region is of utmost importance. In the developed algorithm, a
heuristic regularization term is introduced to ensure smooth deformation fields,
especially in regions with limited anatomical information, and suppress physi-
cally implausible deformations.
In some publications also an attempt is made to include more knowledge
into deformable registration approaches. In the work of Brock et al. [157, 158],
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information of biomechanical behavior of tissue is included in the registration
algorithm. However, biomechanical parameters are not exactly known for the
various tissues and are assumed to be homogeneous and isotropic within the
approach. Also, segmentations of different tissue types have to be available
beforehand for the application of this concept.
Multi-institution studies may be the best way for a comprehensive comparison
of different registration algorithms [159]. In future, a comprehensive dataset of
MR and CT images of HNC patients, with pre-defined annotations for quanti-
tative evaluation could be established for this purpose.
Registration of PET/MR data to the planning CT could be facilitated by
imaging the patient in RT-specific position in the PET/MR scanner. However,
particular hardware solutions for this purpose are not yet commercially available.
One such solution is currently being developed and evaluated with respect to
image quality [141,160]. Even with the possibility of applying positioning aids in
PET/MR it is likely that slight deformations between PET/MR and CT remain,
and deformable registration may still be favorable over rigid registration alone.
Further potential applications of deformable registration in RT are the assess-
ment of local treatment response, as well as failure analysis in case that recur-
rences are discovered in follow-up imaging. In these cases changes in patient
geometry have to be accounted for, which only can be realized with deformable
algorithms.
The co-segmentation algorithm for the derivation of tumor volumes from the
combination of FDG-PET and T2-weighted MR images (Part II ) yielded an
accuracy that lies within variations between manual contours drawn by three
independent observers. The study also showed that the combination of PET
and MRI information for tumor volume definition reduced inter-observer varia-
tions compared to MRI alone. This supports the assumption that multimodal
imaging improves tumor delineation. Variability of tumor delineation may be
further reduced by including additional imaging methods, for example further
MR sequences. This hypothesis should be evaluated in future studies.
Since the algorithm has a modular design, it is easy to include additional
modalities into the co-segmentation process. However, it could also be evaluated
in future if, instead of a linear combination of single-modality tumor probabil-
ity maps, a more complex combination of different imaging information would
be more appropriate for the segmentation process. From an image processing
point of view the integration of quantitative imaging data, such as quantitative
parameter maps from functional imaging, or maps of MR relaxation times T1
and T2, into the segmentation algorithm is most straightforward.
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The developed algorithm should in future ideally be validated on histological
tissue sections, which provide a ground truth for the local classification into
tumor and normal tissue. As for registration, multi-institution studies would
provide a basis to compare the accuracy and robustness of different segmentation
approaches.
Multiparametric functional imaging may allow for a comprehensive biological
tumor characterization and the individual adaptation of treatment strategies.
As a first step towards such concepts, pairwise correlation analyses of FDG-
PET, FMISO-PET, DCE-MRI and DW-MRI data were motivated and per-
formed (Part III ). The results revealed distinct correlations for individual pa-
tients only, while high inter-patient variabilities with weak correlations in the
median were obtained.
Since no general correlations between the functional datasets were observed,
each method may be of separate value for treatment adaptations. However,
general relations could still be present in the combination of three or more
datasets. Machine learning approaches could be used to address this question in
more detail. Results of such studies may in future contribute to the integration
of functional PET/MR data into individualized therapy concepts. Additional
evaluations, such as the analysis of the relationship between complementary
functional imaging data and treatment outcome, will have to be performed in
order to finally define biologically adapted treatment strategies.
Outlook
Combined PET/MR is highly promising for RT as it provides comprehensive
anatomical, functional and molecular information. At least in the near future
CT will remain an important imaging modality for RT due to its value for RT
dose calculation and easy implementation in the RT treatment room as a cone
beam CT device. However, MR-based treatment planning (cf. Section 3.3.2),
and MR image guidance in the treatment room are currently being developed.
For the latter, prototype MR-linac systems have already been developed and
first systems are commercially available [31,161,162].
It is not clear yet if combined PET/MR will be established in clinical practice
as it is the case for PET/CT. The advantages over the usage of PET/CT in com-
bination with stand-alone MR scanners are intrinsic co-registration of PET/MR
data, the simplified logistics, and the saving of the CT radiation if CT could
be omitted in the treatment planning process. If combined PET/MR does not
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prevail in future the general concepts and methods of this thesis remain valid,
but would have to be applied to PET and MR data from separate devices. In
this case, an accurate previous registration of PET and MR datasets would a
prerequisite. PET/MR imaging is promising in all steps of the RT workflow
that require imaging data (cf. Figure 3.2). Further research is necessary before
the full potential of PET/MR imaging for RT can be exploited.
With the development towards multimodality imaging, automatic image pro-
cessing will become more important. A large amount of different datasets is not
manageable by a human observer alone. Moreover, with automatic algorithms a
higher degree of standardization in treatment decision, planning and evaluation
can be achieved. Additional image processing approaches for local characteri-
zation of tumors, such as texture analysis, are recently being evaluated for RT
purposes [163, 164]. With the increase of imaging data, as well as of datasets
derived from the original images, machine learning approaches are likely to be-
come more important as a methodology for dimensionality reduction and the
relation of datasets to clinical endpoints.
The benefit of PET/MR in RT tumor volume delineation, biologically adapted
dose prescription, and response assessment has finally to be assessed in clinical
studies. Individualized treatment concepts will hopefully lead to a reduction of
the number of local treatment failures and a better patient outcome.
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